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KATANİN P60 PROTEİNİ İLE ETKİLEŞEN PROTEİNLERİN BELİRLENMESİ 
 
ÖZET 
 
Katanin mikrotubul kesme özelliği ile hücre iskeleti dinamiğinde önemli görevlere sahiptir. 
Uzun mikrotubuller hareketsiz iken katanin tarafından kesilip küçük parçalara ayrılan 
mikrotubuller hareketlilik kazanırlar ve böylelikle hücre iskeleti organizasyonlarına 
katılabilirler. Bu kısa ve hareketli mikrotubuller, yeni nörit oluşumunda kullanılmaları 
bakımından özellikle nöronlar için son derece önemlidirler. Katanin, p60 katalitik ve p80 
düzenleyici olmak üzere iki alt birime sahiptir. p60, p80 tarafından yönlendirildiği 
sentrozomlarda altılı bir yapı oluşturup, ATP hidroliziyle mikrotubulu keser. Ancak katanin 
p60 alt biriminin p80 alt biriminden farklı bir protein ile etkileşimi henüz gösterilmemiştir. Bu 
nedenle çalışmanın amacı katanin p60 ile etkileşime giren proteinlerin aydınlatılması olarak 
belirlenmiştir. Yeni protein etkileşimlerinin aydınlatılması için cDNA havuz çalışmalarda 
kullanılabilecek en iyi yöntem olan maya ikili hibrid sistemi kullanılmıştır. Etkileşime girecek 
olan proteinler insan embriyonik beyin cDNA kütüphanesinden seçilmiştir. Katanin p60 geni 
işaretçi gen transkripsiyon faktörünün DNA dizisine bağlandığı alt birimle birleştirilmiştir. 
P60’ın etkileşebileceği olası genleri içeren kütüphane de transkripsiyon faktörünün aktivasyon 
alt birimiyle birleştirilmiştir. Her bir plazmid farklı çiftleşme tipine sahip mayalara (S. 
cerevisiae) yerleştirildikten sonra bu suşların çiftleşmesi sağlanmıştır. Oluşan diploit mayalar, 
işaretçi genin aktivasyonu ile seçilmiştir. Mayaların çiftleşmesi sonucunda p60 ile etkileşen 
22 proteinin etkileşimi doğrulanmıştır.   
Katanin mikrotubul kesme özelliği ile mikrotubul dinamiği ve hücre iskeleti oluşumunda 
önemlidir. Bu sebeple katanin p60 ile etkileşime giren proteinlerin aydınlatılması, kataninin 
bu proteinlerle etkileşmesi sonucu sinir hücresi içindeki olası diğer rollerinin ortaya 
çıkartılması açısından sinir bilimi literatürü için çok önemlidir. 
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IDENTIFICATION OF KATANIN P60 INTERACTING NEURONAL PROTEINS 
 
SUMMARY 
 
Katanin has important functions in cytoskeletal dynamics through its microtubule severing 
activity. Long microtubules are stationary, whereas short microtubule fragments severed via 
katanin achieve motility and could contribute into cytoskeletal organizations. These short and 
motile microtubules are especially essential for neuronal branching. Katanin protein consists 
of two domains; p60 catalytic domain and p80 regulatory domain. P80 directs p60 to the 
centrosomes where p60 forms hexameric structure and severs microtubule by ATP hydrolysis. 
Nevertheless, there is no identified interaction of katanin with any protein except p80. Thus, 
purpose of this study was to identify katanin p60 interacting proteins in neuronal cells. In this 
study Yeast Two Hybrid System, which is the best method for detection of novel protein 
interactions from cDNA pool, was chosen for identification of new katanin p60 interacting 
proteins. “Clontech Matchmaker Yeast Two Hybrid” kit was used for this study and new 
interacting proteins were selected from fetal human brain cDNA library. Katanin p60 gene 
was fused with DNA binding domain of transcription factor of reporter gene and cDNA 
library was fused with activation domain of the same transcription factor.  Each fusion 
construct was inserted into different mating types of S. cerevisiae and strains were mated.  
Following mating, diploid yeast cells were selected through reporter gene activation. 22 new 
protein interactions were identified and confirmed. 
Katanin is a critical protein in microtubule dynamics and has roles in many important cellular 
activities. Therefore, elucidation of katanin p60 interacting proteins, revealing possible 
diverse roles of katanin in neurons through discovered interactions would provide significant 
data for neuroscience literature. 
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1. INTRODUCTION 
1.1. Theoretical Background 
1.1.1. Cytoskeleton 
Cytoskeleton is a scaffold of proteins present in cytoplasm (immunostained 
cytoskeletal proteins can be seen in Fig. 1.1). Cytoskeleton is a dynamic structure; 
thus, none of the construction is stable. In fact they are continuously assembling and 
dissembling. Cytoskeletal fibers assemble via polymerization of protein subunits, and 
disassemble via depolymerization into protein subunits.  
Cytoskeleton has many important functions in the cell. Foremost, preservation of cell 
shape and maintenance of mechanical strength of the cell are attained by 
cytoskeleton. Furthermore, cell movement is achieved through cytoskeletal fiber 
organizations, e.g. flagella, cilia and pseudopodia. Moreover, intracellular 
transportation of molecules, mRNA, filaments, vesicles, and even organelles, is 
accomplished via motor proteins “walking” over cytoskeletal fibers. Last, but not the 
least, cytoskeletal elements function in cell division. 
 
Figure 1.1 Cytoskeleton (tubulins are yellow, actins are blue). (Wittmann, 2006) 
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Cytoskeletal fibers are separated into 3 groups, each formed from different subunits; 
intermediate filaments, microfilaments and microtubules. Intermediate elements are 
responsible of the shape and strength. These filaments are more durable than other 
cytoskeletal elements. Microfilaments are composed of bead-like dimeric actin 
molecules and also function in the attainment of cell shape and mechanical support 
and also in movement. Actin fibers take role in muscle contraction in vertebrates and 
form pseudopodia in amoeba and erythrocytes. Microtubules are hollow cylinders 
composed of α-tubulin and β-tubulin. Microtubules are involved in cell division in 
the course of drawing chromosomes to the poles. They also supply the intracellular 
transport and cellular movement (Alberts et al., 2003).  
1.1.2. Microtubules 
1.1.2.1. Structure and Organization of Microtubules 
Microtubules, hollow cylinders with 25 nm diameter, are composed of α-tubulin and 
β-tubulin. Initially, α-tubulin and β-tubulin form heterodimer, subsequently these 
heterodimers build the structure of microtubules. Microtubule structure is 
demonstrated in Fig. 1.2. α-tubulin and β-tubulin consist of 40 amino acids and 
amino acid sequences are 50 % identical (Burns, 1991). Each monomer of 
heterodimer binds to a GTP molecule; α-tubulin binds to GTP non-exchangeable, 
whereas β-tubulin binds exchangeable fashion. GTP bound to β-tubulin is utilized 
during polymerization of tubulin. 
 
Figure 1.2 Microtubule structure (Valiron et al., 2001) 
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The centrosomes, consisting of 2 centrioles surrounded by an amorphous cloud of 
pericentriolar material, are the primary source of microtubule nucleation in 
eukaryotes. Pericentriolar material contains the γ-tubulin ring complexes (γ-TuRC) 
which are in charge of nucleating microtubules (Ahmad et al. 1994). γ-tubulins are 
arranged into circular ring structures in centrosomal pericentriole regions and 
nucleation from these structures apparently restricts the lattice structure of 
microtubule to 13 protofilaments (Baas, 1997). γ-TuRC has proteins additional to γ-
tubulin, for instance ninein (Mogensen et al. 2000), functions in attaching γ-tubulin 
rings to pericentriole. 
The organization of α- and β-tubulin heterodimers in the microtubule lattice is 
polarized, and structural and kinetic differences are resulted from this characteristic 
at the microtubule ends. The faster growing end (plus end) has the β-tubulin subunit 
of each heterodimer exposed, whereas the slower growing end (minus end) has the α-
tubulin subunit exposed. In vivo, the minus end of the microtubule is associated with 
the γ-TuRC complex. Microtubule nucleation and polarity are illustrated in Fig 1.3. 
.  
Figure 1.3 Microtubule nucleation and polarity (Lüders and Stearns, 2007) 
1.1.2.2. Microtubule Dynamics  
Elongation of the microtubule is arisen from the polymerization of tubulins. As 
mentioned before, α- and β-tubulins initially assemble into dimmers; afterward, they 
construct protofilaments. Each of the protofilaments consists of a head-to-tail 
arrangement of α-/β-tubulin heterodimers. When bound to GDP, the tubulin dimer is 
in a bent conformation, which assembles poorly into microtubule lattice. These 
conformation differences are demonstrated in Fig. 1.4. Exchange of GTP into its 
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active site straightens the dimer, facilitating its incorporation into a sheet at the 
growing end of the microtubule (Walczak, 2000). When sheet of 13 protofilament is 
sealed as a hollow cylinder, consequently microtubule lattice is build.  
 
Figure 1.4 Illustrations of conformation change due to bound nucleotide in tubulin 
heterodimer (Nogales and Wang, 2006) 
Microtubules comprising GTP-bound tubulin at the plus end are stable since these 
GTP caps strengthen the lattice of microtubule. Therefore, microtubules with 
tubulin-GTP continue to elongate (Caplow and Shanks, 1996). This phase is 
emphasized as microtubule growth phase. As soon as the GTP cap of microtubule is 
detached, the lattice of microtubule becomes unstable and protofilaments are peeled 
from the lattice (Desai and Mitchison, 1997). This phase is known as shrinkage. 
Microtubules are switching between growth and shrinkage phases. This feature is 
entitled as dynamic instability (Fig. 1.5).    
5 
 
 
Figure 1.5 Demonstration of dynamic instability (Wiese and Zheng, 2006) 
Many microtubule interacting proteins are found. These proteins regulate the 
dynamics of microtubule organization. Microtubule interacting proteins are classified 
into two main groups: proteins that stabilize microtubules and proteins that 
destabilize microtubules. Microtubule associated proteins (MAPs) are known to 
stabilize microtubules by enhancing the rate of microtubule growth and suppressing 
the transitions from a growing phase to a shrinking state catastrophe (Drechsel et al., 
1992; Kowalski and Williams, 1993). Microtubule destabilizing proteins are 
discovered since microtubule turnover in vivo is faster than in vitro (Cassimeris et al., 
1988; Simon et al., 1992). Op18 (Belmont and Mitchison, 1996), XKCM1 (Walczak 
et al., 1996), katanin (Vale, 1991) are best known microtubule destabilizing proteins. 
Both the structure of the lattice and the polarity of the microtubule are central to the 
function of microtubule motor proteins which are able to move on microtubules. 
There are two basic types of microtubule motors: plus-end motors and minus-end 
motors, depending on the direction in which they "walk" along the microtubules. 
Kinesins and dyneins are examples of microtubule motor proteins. 
1.1.2.3. Microtubule Functions 
Microtubules are crucial for many intracellular functions. During interphase, 
microtubules are required for organizing large intracellular membrane compartments, 
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such as the Golgi apparatus (Ho et al., 1990) and the endoplasmic reticulum 
(Terasaki et al.,1986), as well as for transporting small membrane carrier vesicles in 
the endocytotic and secretory pathways (Vale, 1987). During mitosis, microtubules 
are the primary constituents of the mitotic spindle and are needed for proper 
segregation of chromosomes (Rappaport, 1985).  
 
Figure 1.6 Organisation of microtubule in mitotic and interphase cells (Weise and 
Zheng, 2006) 
Microtubules serve extensively important functions in some specialized cells like 
neurons. Microtubules in neurons are not employed for spindle formation; but rather, 
they function in elongation of axons (Karabay et al., 2004). Crucial events for axonal 
differentiation such as elongation, branching, navigation, retraction, are 
accomplished by changes in the configuration and behavior of microtubules (Baas 
and Buster, 2004). Microtubules also serve as roadway for transport of organalles in 
both directions. Although microtubules are nucleated from centrosomes, they are 
transported to different intracellular domains in neurons (Fig. 1.7). One important 
target for microtubule transport is the axon. Neurons comprise a unique microtubule 
organization wherein microtubule bundles are located in axons and dendrites, and 
these microtubules are originally constructed at centrosomes (Baas, 1999). 
Microtubule is released from minus end or severed by a severing enzyme and 
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transport of these non-centromal microtubules are conveyed by motor proteins 
(Keating et al, 1997).  
Figure1.7 Microtubule organization in neurons (Baas et al, 2005). 
1.1.3. Katanin 
Microtubule severing is originally discovered in sea urchin lysate through observed 
shortening of microtubules (Vale, 1991). Microtubule severing protein is later 
identified as katanin for the namesake of the Japanese samurai sword, katana. 
Characterization of katanin reveals that katanin disrupts the lattice of microtubule in 
an ATP hydrolysis driven fashion (McNally and Vale, 1993).  
Katanin comprise an AAA ATPase domain (ATPases Assoiated with various cellular 
Activities). Members of this domain are involved in various protein-protein 
interactions and function in a myriad of important cellular activities. Each protein 
conferred with one or two of 230-residue ATPase module which is conserved 
extensively with ~30% identity (Confalonieri and Duguet, 1995; Patel and Latterich, 
1998). AAA proteins are prevalently act as hexameric rings since AAA core contains 
subunit-subunit interactions (Vale, 2000). 
Katanin is a heterodimer consisting of 60-kDa and 80-kDa subunits. 60 kDa subunit 
is known as katanin p60; it is the catalytic subunit and comprises AAA ATPase 
domain. 80 kDa subunit is known as katanin p80; it is the regulatory domain and it 
has WD repeats in its protein structure for protein-protein interactions. p80 subunit is 
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not responsible for microtubule severing; however, it directs p60 to centrosomes 
since it has centrosome interaction domains. Catalytic activity of katanin p60 
hexameric ring does not require the presence of p80. However, in the presence of 
p80, severing activity of p60 increases two fold (Hartman et al. 1998). Katanin is a 
severing protein conferred with microtubule driven ATP hydrolysis (Hartman and 
Vale, 1999). 
Severing of microtubule is substoichiometrical; thus, one katanin protein is able to 
release more than one tubulin subunit. Moreover, released tubulins are able to be 
used in polymerization again; thus katanin do not proteolyze or modify structure of 
tubulins (McNally and Vale, 1993).  
Since the first experiments were performed on sea urchin and Xenopus, vertebrate 
homologous proteins are investigated in later studies. McNally and Thomas isolated 
human katanin homologous protein and also showed the presence of human katanin 
homologous protein in different tissue types (McNally and Thomas, 1998).    
Katanin severs microtubules by generating an internal break on microtubule lattice 
(Shiina et al., 1992; McNally and Vale, 1993). However, the exact mechanism of 
microtubule severing still remains to be unsolved. There is a model postulation for 
katanin severing which states that the microtubules are providing a scaffold for 
katanin 60 subunits to interact and form hexameric catalytic structure (Fig. 1.8). 
When the hexameric katanin p60 forms, it cuts the scaffold microtubules (Hartman 
and Vale, 1999). 
 
Figure 1.8 Severing of microtubules with katanin (Hartman and Vale, 1999)  
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Severing of microtubules with katanin has potential functions in several changes in 
the microtubule cytoskeleton observed in vivo. Katanin is found to be localized near 
centrosomes (McNally et al., 1996).  Poleward flux of tubulin to centrosome in 
mitotic spindle require microtubule disassembly (Mitchison, 1989), katanin may 
disassemble microtubules in order to generate poleward flux or it just cuts from γ-
tubulin  (Moritz et al., 1995; Zheng et al., 1995). Since it is found that microtubules 
have their minus ends unattached from centrosome (Kitanishi-Yumura and Fukui, 
1987) katanin may take role in the release of microtubule from centrosome. Lastly, 
fast depolymerization of microtubules in G2/M transition (Zhai et al., 1996) may be 
generated by katanin. 
Neurons comprise highly abundant and specialized microtubule organization thus 
katanin serves extensively important functions in neurons. Structurally, axon is 
composed of bundles of microtubule where plus ends of axonal microtubules are not 
GTP capped but it is highly stable. This stabilization may present due to 
transportation of new microtubules to the axon from centrosomal sites (Karabay et 
al., 2004). Microtubules are cut in the centrosomal sites and they are conveyed to 
dendritic or axonal site (Baas et al., 2005) since these locations require microtubules 
for structural support and transport of materials (Quarmby, 2000).  
In order to provide microtubule fragments for axonal and dendritic processes, 
“microtubule cut and run model” is recruited (Fig 1.9). Rationale of model is as 
followed; long stationary microtubules are severed into small fragments of 
microtubules and these newly generated small microtubules are transported with 
dyneins to axonal and dendritic processes (Baas et al., 2005). 
10 
 
 
 Figure 1.9 Microtubules cut and run mode (Baas et al., 2005). 
Severing activity of katanin is regulated by the presence of MAP4 in mitotic 
fibroblast cells (McNally et al., 2002) and tau in neurons (Qiang et al., 2006). Both 
MAP4 and tau are strong microtubule binding proteins; therefore they reduce the 
access of katanin to microtubule. Recent studies reveal that katanin is present 
throughout the axonal microtubules; however, katanin is able to reach only tau 
unoccupied microtubule sites (Yu et al., 2008). 
1.2. Experimental Background 
1.2.1. Yeast Two hybrid 
The method is based on the modular properties of GAL4 transcription factor which 
consists of two separable domains of DNA-binding and transcriptional activation 
(Fig 1.10) (Keegan et al., 1986). In fact, many eukaryotic transcription activators 
comprise at least two distinct functional domains, one that directs binding to a 
promoter DNA sequence and one that activates transcription (Hope and Struhl, 
1986).  
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Figure 1.10 Native GAL4 protein dimer in association with DNA (Protein Database, 
P04386) 
Plasmids encoding two hybrid proteins, one consisting of the GAL4 DNA-binding 
domain fused to protein of interest (bait) and the other consisting of the GAL4 
activation domain fused to cDNA library (prey), are constructed and introduced into 
yeast (Fig. 1.11). Reporter gene with GAL4 promoter region is activated with 
interaction between bait and prey domains (Fields and Song, 1989; Chien et al., 
1991). 
 
Figure 1.11 Principle of Yeast Two Hybrid Technique, (A), (B) Two fusion proteins, one containing 
the DNA-binding domain (DB: blue circle) and one that contains an activation domain (AD: half blue 
circle), are co-transfected into an appropriate host strain. (C) If the fusion partners (yellow and red) 
interact, the DB and AD are brought into proximity and can activate transcription of reporter genes 
(Van Criekinge and Beyaert, 1999). 
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This technology can be used for identifying novel protein interactions, confirming 
suspected interactions, and defining interacting domains.  
1.2.2. Reporter Genes 
In this study, Clontech Yeast Two Hybrid product family is employed; since 
Clontech's Matchmaker Yeast Strain AH109 expresses four integrated reporter genes 
in response to two-hybrid interactions under the control of distinct GAL4-responsive 
upstream activating sequences (UASs) and TATA boxes (Fig. 1.12). Therefore, each 
gene is transcribed from a distinct promoter sequence. Consequently library proteins 
that bind to flanking regions of promoter, are eliminated. 
 
Figure 1.12 Reporter genes: Promotor regions for GAL4 protein in AH109 and 
Y187 strain. (Clontech, 2005) 
Here is the list of reporter genes: 
HIS3. AH109 is unable to synthesize histidine and is therefore unable to grow on 
media that lack this essential amino acid. When bait and prey proteins interact, Gal4-
responsive His3 expression permits the cell to biosynthesize histidine and grow on a 
his- minimal medium. 
ADE2. AH109 is also unable to grow on minimal media that does not contain 
adenine. However, when two proteins interact, Ade2 expression is activated, 
allowing these cells to grow on ade- minimal medium. 
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MEL1. MEL-1 encodes α-galactosidase, an enzyme occurring naturally in many 
yeast strains. As a result of two-hybrid interactions, a-galactosidase (MEL1) is 
expressed and secreted by the yeast cells. Yeast colonies that express Mel1 turn blue 
in the presence of the chromagenic substrate X-α-Gal. 
LacZ. Lac Z encodes ß-galactosidase (ß-Gal), an E.coli enzyme which is integrated 
into the AH109 chromosome. As a result of two-hybrid interactions, ß-galactosidase 
is expressed, but not secreted. Thus, only if the cells are lysed, as in a colony lift 
assay, can a blue color be detected in the presence of X-Gal. In contrast, X-α-Gal 
detection allows blue colonies to be visualized directly on the growth medium. 
1.2.3. Advantages and Limitations for Yeast Two Hybrid 
Yeast Two Hybrid technique comprises advantageous and disadvantageous 
properties, as with any technique. On one hand it is cheap, easy to perform and 
allows screening a large number of proteins. On the other hand, interaction medium 
is restrained to yeast nucleus, false positives and false negatives can arise, membrane 
bound proteins are not assayed properly (Hollingsworth and White, 2004). 
Table 1.1 Advantages and Limitations for Yeast Two Hybrid 
Advantages Limitation 
 
• Cheap, simple and versatile 
• In vivo protein interaction analysis 
• Capable of detecting weak or even 
transient interactions 
• Can be used to identify novel 
interactors by cDNA library screening 
• Several variations allow multiple 
applications 
• Can be scaled up through automation 
for genomic-scale protein interaction 
mapping 
• Yeast cell environment may not fully 
mimic mammalian cells (e.g. post-
translational modifications may not be 
replicated in yeast) 
• Interactions are assayed in the yeast 
nucleus rather than the correct cellular 
compartment 
• Membrane-bound proteins and 
transcription are often not suitable (since 
Y2H forces proteins into the 
nucleoplasm and relies on transcriptional 
activation as a read-out). 
• False positives and false negatives can 
occur 
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1.3. Aim of the study 
Katanin is an extremely important protein for all cell types because of cytoskeletal 
arrangements which are essential for each cell.   
Since microtubules are employed for axonal elongation instead of spindle formation 
in neurons, microtubule organizations are extensively involved in axonal 
differentiation. Axonal differentiation occurs at distant places from the cell body and 
rearrangements of cytoskeletal elements are required for axon processes; therefore, 
microtubules should be transported to dendritic and axonal process sites. For this 
purpose, microtubules are severed with katanin and transported to differentiation site 
with motor proteins. Consequently, katanin is involved in neuronal differentiation via 
microtubule severing property. 
Katanin may also comprise a function in regeneration of neuronal injuries. The 
damaged axons may be reconstituted with microtubules that are generated via 
microtubule severing. Moreover, katanin may also function in regeneration of new 
branching sites.  Importance of katanin with neurodegenerative diseases may be 
derived from this property.   
In molecular learning, the hypothesis is that neurons form new connection with their 
target sites. This neuron targeting requires new cytoskeletal rearrangements. Katanin 
may involve in molecular learning models with its recruitment in formation of new 
axonal processes to prospective target neurons via its microtubule severing property. 
Although the structure of katanin is studied extensively, protein interaction pattern of 
katanin still remaines to be discovered. Known katanin p60 interactions are restricted 
with microtubule, p80 subunit and p60 itself. Since katanin has exceptionally 
essential functions in neurons; it possibly interacts with many more proteins and 
accordingly involves in many neuronal pathways.   
In this study, protein interactions of katanin in whole human fetal brain are 
examined. Results of the study can enlighten the protein interactions hence other 
possible functions of katanin. 
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2. MATERIALS AND METHOD 
2.1. MATERIALS 
2.1.1. Equipments 
The equipments employed in this study are illustrated in the table below: 
Table 2.1 Equipment 
Equipment Supplier Company 
DNA sequencer Applied Biosciences 3100 Avant 
Electrophoresis Gel System E-C Apparatus Corporation, EC250-90 
Minicel Primo 
Microcentrifuge Beckman Coultier 
pH Meter Mettler Toledo MP220 
Precision Weigher Precisa 620C SCS 
Shaker Forma 
UVIPhoto MW Version 99.05 for 
Windows 95 & 98 
UVItec Ltd. 
UV Transilluminator Biorad UV Transilluminator 2000 
Vortex Heidolph, Reaxtop 
Water Bath Memmert 
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2.2. Chemicals 
The chemicals used in this study are listed in the table below: 
Table 2.2 Chemicals 
Chemical Supplier Company 
Low Melting Agarose 
X-gal Applichem 
PIPES BDH Laboratory  
YPD liquid Medium 
YPD AgarMedium 
SD Medium 
SD Agar Medium 
-Trp/-Leu Drop-out Amino acid Mixture 
-His/-Leu/-Trp Drop-out Amino acid 
Mixture 
-Ade/-His/-Leu/-Trp Drop-out Amino 
Acid  Mixture 
Clontech 
MgCl2 
dNTP Mix 
DNA ladder 
DNA loading Dye 
Fermentas 
Isopopanol 
CaCl2 
Glycerol 
NaCl 
Glacial Acid 
Fluka 
p60 specific primers  Integrated DNA Technologies 
pACT2-pGBKT7 specific primers Alpha DNA  
Tryptone Lab M TM 
Glucose 
EDTA 
EtBr 
Tris Base 
Yeast Extract 
Agar  
KCl 
MgCl2 
Merck 
Na2HPO4 
NaH2PO4 
 
J.T. Baker 
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2.1.3. Enzymes and Buffers 
Enzymes and buffers used in this study are given in the table below: 
Table 2.3 Enzymes and buffers 
Product Supplier Company 
Long Pcr Enzyme Mix 
Taq polymerase 
Cfr9I (XmaI) restriction enzyme 
Sal I restriction enzyme 
HindIII Restriction Enzyme 
10X Taq Polymerase Buffer 
10X Long PCR Enzyme Mix Buffer 
Fermentas 
T4 ligase 
T4 ligase buffer Roche 
Lyticase from Anthrobacter luteus Sigma 
 
2.1.4. Commercial Kits  
Commercial kits used in this study are illustrated in the table below: 
Table 2.4 Commercial Kits 
Kit Supplier Company 
High Pure Plasmid Purificatin Kit Roche 
QiaPrep Spin Miniprep Kit  Qiagen 
Qiagen Plasmid Maxi Prep Qiagen 
Bid Dye Terminator v 3.1 Cycle 
Sequencing Kit 
Applied Biosystems 
The Yeastmaker Yeast Transformation 
System 2 
Clontech 
Pretransformed fetal human brain cDNA 
library 
Clontech 
 
2.1.5. Buffer and Solutions: 
Buffers and solutions used in this study are illustrated in the table below: 
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Table 2.5 Buffers and Solutions 
Buffer/Solution Content 
TAE Buffer (50X) 40 mM Tris Base 
20mM Glacial acetic acid 
1 mM EDTA (pH 8.) 
dH2O 
CaCl2 Solution 60 mM CaCl2 
10mM PIPES 
15% glycerol 
dH2O 
TE/LiAc Solution 110 mM LiAc 
1.1 X TE  
PEG/LiAc Solution %40 (w/v) PEG 4000 
100 mM 
1X TE 
Buffer Z 60 mM Na2HPO4 
40 mM NaH2PO4 
10 mM KCl  
10 mM MgSO4 
dH2O (pH 7.0 with HCl) 
2.1.6. Microorganism Strains 
2.1.6.1. Bacterial Strains 
Escherichia coli (E.coli) DH5α strain [F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, 
deoR, recA1, endA1, hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1] 
2.1.6.2. Yeast strains 
Saccharomyces cerevisiae (S. cerevisiae) AH 109 strain [MATa, trp1-901, leu2-3, 
112, ura3-52, his3-200, gal4Δ, gal80Δ,LYS2 : : GAL1UAS-GAL1TATA-HIS3, 
GAL2UAS-GAL2TATA-ADE2 URA3 : : MEL1UAS-MEL1TATA-LacZ], 
Clontech 
Saccharomyces cerevisiae (S. cerevisiae) Y187 strain [MATα, ura3-52, his3-200, 
ade2-101, trp1-901, leu2-3, 112, gal4Δ, gal80Δ, met–, URA3 : : GAL1UAS-
GAL1TATA-LacZ MEL1], Clontech 
2.1.7. Culture Media 
Luria Bertani (LB) Medium: 10 gram (g) tryptone, 5 g yeast extract, and 10 g NaCl 
were dissolved in distilled water and the volume was adjusted to 1 L. The media was 
sterilized by autoclaving for 15 minutes. In order to make selection media, antibiotics 
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were added to the LB medium after sterilization was completed and the media was 
cooled down to approximately 55 °C. Stock and working concentrations of used 
antibiotics are given below:   
Table 2.6 Stock and Working Solutions of Antibiotics 
Antibiotic Stock Solution 
Concentration 
Working  Solution 
Concentration 
Kanamycin 10 mg/L in distilled water 50 μg/L 
Ampicillin   10 mg/L in distilled water 50 μg/L 
 
Agar plates were prepared by adding 20 g/L to LB Medium solution and sterilized at 
121 °C with autoclaving for 15 minutes.  
SOC medium was used to cultivate E. coli cells after heat shock transformation. 2 g 
tryptone, 5 g yeast extract, 0.058 g NaCl, 0.0186 g KCl, 0.095 g MgCl2, and 0.23 
MgSO4 were dissolved in 80 ml distilled water and sterilized at 121 °C with 
autoclaving for 15 minutes. 0.36 g glucose was dissolved in 20 ml distilled water and 
solution was sterilized with filter-sterilizaton. These two sterile solutions were mixed 
and used. 
YPD (Yeast Peptone Dextrose) medium was prepared by dissolving 20 g of Difco 
peptone, 10 g of yeast extract, and 2 g of dextrose in 1 L distilled water. The media 
was sterilized by autoclaving for 15 minutes.  
In order to make agar plates, 20 g/L agar was added to ingredients then autoclaving 
for 15 minutes was performed.  
In order to make Adenine supplemented YPD, medium was prepared as standard 
YPD preparation, after autoclaving 1.5 ml of filter-sterilized 2% Adenine 
hemisulfate (w/v) was added to medium. 
SD (Synthetic Dextrose) medium was prepared by dissolving 20 g dextrose, 6.7 g 
yeast nitrogen base without amino acids, in 1 L distilled water. 20 g agar was added 
to SD ingredients in order to prepare SD Agar plates. Appropriate drop-out amino 
acid mixtures were added to SD before sterilization with autoclaving for 15 minutes. 
Final concentrations of additive amino acids are given in the table below: 
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Table 2.7 Amino acid supplement final concentrations 
Nutrient Final concentration 
L-Adenine hemisulfate salt 20 mg/L 
L-Arginine HCl 20 mg/L 
L-Histidine HCl monohydrate 20 mg/L 
L-Isoleucine 30 mg/L 
L-Leucine 100 mg/L 
L-Lysine HCl 30 mg/L 
L-Methionine 20 mg/L 
L-Phenylalanine 50 mg/L 
L-Threonine  200 mg/L 
L-Tryptophan 20 mg/L 
L-Tyrosine 30 mg/L 
L-Uracil 20 mg/L 
L-Valine 150 mg/L 
 
2.1.8. Vectors  
2.1.8.1. DNA Binding Domain Vector, pGBKT7 
The pGBKT7 vector expresses proteins fused to amino acids 1–147 of the GAL4 
DNA binding domain (DNA-BD). In yeast, fusion proteins are expressed at high 
levels from the constitutive ADH1 promoter (PADH1); transcription is terminated by 
the T7 and ADH1 transcription termination signals (TT7 & ADH1). pGBKT7 also 
contains the T7 promoter, a c-Myc epitope tag, and a MCS. pGBKT7 replicates 
autonomously in both E. coli and S. cerevisiae from the pUC and 2 μ ori, 
respectively. The vector carries the Kanr for selection in E. coli and the TRP1 
nutritional marker for selection in yeast. Yeast strains containing pGBKT7 exhibit 
higher transformation efficiency than strains carrying other DNA-BD domain 
vectors. 
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Figure 2.1 Restriction map and multiple cloning site of pGBKT7 vector 
 
2.1.8.2. Activation Domain Vector, pACT2 
pACT2 generates a fusion of the GAL4 AD (amino acids 768–881), an HA epitope 
tag, and a protein of interest (or protein encoded by a cDNA in a fusion library) 
cloned into the MCS in the correct orientation and reading frame. pACT2, which is 
derived from pACT , contains a unique EcoR I site in the MCS. The hybrid protein is 
expressed at high levels in yeast host cells from the constitutive ADH1 promoter (P); 
transcription is terminated at the ADH1 transcription termination signal (T). The 
protein is targeted to the yeast nucleus by the nuclear localization sequence from 
SV40 T-antigen which has been cloned into the 5’ end of the GAL4 AD sequence. 
pACT2 is a shuttle vector that replicates autonomously in both E. coli and S. 
cerevisiae and carries the bla gene, which confers ampicillin resistance in E. coli. 
pACT2 also contains the LEU2 nutritional gene that allows yeast auxotrophs to grow 
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on limiting synthetic media. Transformants with AD/library plasmids can be selected 
by complementation by the LEU2 gene by using an E. coli strain that carries a leuB 
mutation (e.g., HB101). 
 
Figure 2.2 Restriction map and multiple cloning site of pACT2 plasmid.  
 
2.2. METHODS  
2.2.1. Bait Plasmid Construction 
2.2.1.1. Primer Design 
Homo sapiens katanin p60 is present as inserted in pEGFP. Since restriction sites in 
this plasmid are not suitable, primers with appropriate flanking restriction site were 
designed for the gene by considering the general rules of primer design. For instance, 
primers should not form a secondary structure which prevents annealing to the 
template and GC content of primers should not exceed 40%. The sequence 
information of p60 was taken from http://www.ncbi.nih.gov/ NM_007044 
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2.2.1.2. PCR of p60 cDNA 
Polymerase Chain Reaction is used to amplify a fragment from template DNA 
sequence. Borders of amplified fragments are defined with small oligonuclotides 
called primers. These primers provide a binding site on template DNA for DNA 
polymerases. Polymerases are able to work in vitro and preserve their natural 
conformation at high temperature as 95 °C which is used to denature template DNA 
thoroughly. For this purpose, thermophilic bacteria DNA polymerases are used. The 
buffers are added to preserve DNA polymerase in its natural confirmation. dNTP 
molecules are added to be integrated into recently forming DNA molecules. The 
theory of PCR is as followed; DNA denaturates at high temperature, primers bind to 
single stranded template DNA polymerase creates the new DNA fragment. Since 
each newly produced fragment is able to serve as template, the number of DNA 
molecules increases logarithmically. Applied PCR reaction and PCR program is iven 
below: 
Table 2.8 PCR Reaction for cloning p60 cDNA 
Ingredients Stock Solutions Amount for 1X rxn mix 
Long enzyme Buffer (10X) 2.5 μl (1X) 
Forward primer (25 mM) 0.5 μl (0.5 mM) 
Reverse primer (25 mM) 0.5 μl (0.5 mM) 
dNTP (10 mM) 0.5 μl (0.2 mM) 
Template pEGFP-Hsp60 (2ug/ul) 0.1 μl (0.2 ug DNA) 
Long enzyme mix (5u/ul) 0.2 μl (1 unit) 
Sterile mq water 20.7 μl 
Total 25 μl 
 
Table 2.9 PCR program for cloning p60 cDNA 
Initial denaturation (94 
°C)   
: 3 min  
Denaturation (94 °C)           : 15 sec  
Annealing (58 °C)               : 30 sec  
Extension (68 °C)                : 30 sec  
Final extension (68 °C)       : 5 min  
 
PCR products were run on 1% (w/v) low melting agarose-TAE, with 75 mV for 45 
minutes in electrophoresis to determine length of DNA product.  
 
30 loops 
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2.2.1.3. Purification of p60 cDNA PCR product 
After PCR, the fragments were purified with Roche High Pure PCR product 
purification kit. This kit removes the protein contamination derived from polymerase 
enzymes ad nucleic acid contamination derived from primers. The principle of the kit 
is given as followed; DNA is bound to glass fleece with aid of high concentrated 
choatropic salt; remains of protein are removed with washes. Finally, the DNA 
molecules are released with low salt concentration elution buffer. The purification 
protocol is given below: 
• Total volume of PCR product was brought to 100 μl and 500 μl Binding Buffer 
[3 M guanidine-thiocyanate, 10 mM Tris-HCl, 5% ethanol (v/v), 2 mg RNAase, 
pH 6.6 (25° C)] was added to each 100 μl PCR tube. 
• After mixing the sample well, sample was transferred into collection filter tubes 
and centrifuged for 1 minute at 14000 rpm at table top centrifuge. 
• Flow through was discarded and 500 μl Wash buffer [20 mM NaCl, 2 mM Tris-
HCl, 80% ethanol pH 7.5 (25°C)] was added. Then again the filter tube was 
centrifuged at 14000 rpm for 1 minute. 
• Flow through was discarded and 200 μl of Wash Buffer was added. The mixture 
was centrifuged at 14000 rpm for 1 minute. 
• Flow-through was discarded and filter was connected to a clean 1.5 ml eppendorf 
tube. 50 μl of Elution buffer [10 mM Tris-HCl, pH 8.5 (25°C)] was added; then, 
it was centrifuged at 14000 rpm for 1 minute. 
• DNA concentration was determined by subsequent OD260 measurement (An 
OD260 of 1 corresponds to 50 µg/ml).  
2.2.1.4. Restriction of p60 cDNA 
DNA fragments are cut with sticky end restriction enzymes forming nicks in the 
structure of DNA, this phenomenon serves for generating sticky overhangs which 
has ability to complement with a fragment containing same overhang. Some 
restriction enzymes cut bluntly, generating no overhangs. Using this type of 
restriction enzyme can be excruciating when the gene has to be inserted in a 
significant direction.  Purified DNA fragments and target vector pGBKT7 were cut 
with Cfr9I and SalI. The reaction mixture is given in the table below: 
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Table 2.10 Restriction reaction mixture of pGBKT7 and p60 cDNA  
 pGBKT7 Hsp60 
DNA template 10 μl  10 μl 
Fast Digest Buffer 2 μl 2 μl 
Cfr9I 0.5 μl 0.5 μl 
SalI 0.5 μl 0.5 μl 
Sterile mq H2O 7 μl 7 μl 
Total 20 μl 20 μl 
 
The restriction reactions were incubated at 37 °C for 3 hours. The resulting mixture 
was run on gel to understand if the fragments are cut properly. Later, restricted 
fragments were again purified with Roche High Pure PCR Product Purification Kit. 
2.2.1.5. Ligation of p60 cDNA into pGBKT7 vector 
Purified vector and insert gene were ligated with Roche T4 ligase according to 2:15 
molecular ratio. The ligation reaction mixture is given below: 
Table 2.11 Ligation mixture of pGBKT7 and p60 cDNA 
Ingredients  Amount 
Hsp60 (1 μg/ μl) 15 μl
pGBKT7 (0.5 μg/ μl) 2 μl
10X Roche T4 ligation buffer 2.5 μl 
Roche T4 Ligase 1 μl
ATP (5 mM) 4 μl (0,8 mM)
Sterile mq H2O 0.5 μl 
Total  25 μl
 
Ligation mixture was prepared according to concentration in the table and ligation 
was performed at 4 °C overnight. After reaction was terminated by freezing at -20 
°C, 2 μl of reaction mixture was loaded onto 1% TAE agarose gel and run at 70 mV 
for 45 minutes to identify if the fragments were ligated to each other. Then, ligation 
mixture was transformed into competent DH5α E.coli. 
2.2.1.6. Transformation of Constructed pGBKT7-p60 plasmid 
Subsequent to ligation, plasmid constructs were transformed into a bacterial host in 
order to increase the number of plasmids. Since, plasmids contain a constitutive 
replication feature by origin of replication of pUC in high copy number plasmids. 
DNA transfer to bacterial cells is not a spontaneous process since DNA is a 
hydrophilic molecule and membrane has a hydrophobic interface. In nature, cells 
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having ability to import DNA molecule are present. However, this ability requires 
additional specialized channel and proteins for intake of DNA molecule. Cells could 
be modified in order to intake DNA. For this approach; first, cell wall is disrupted 
with CaCl2 and later, DNA binds to disrupted cell wall fractions and finally, DNA is 
introduced into cell with membrane scaring by heat shock. DNA introduction can be 
mediated without chemical treatment. DNA is introduced into cell with an electric 
voltage which creates holes in the structure of membrane. This method is called 
electroporation. The latter method is more efficient but viability of cells decreased 
since voltage application is exceedingly harsh. 
In our lab, CaCl2 treatment based chemical competent cells are used. Escherichia 
coli (E. coli) DH5α cells were modified into competent cells. The chemical 
competent cell preparation protocol (Sambrook et al., 2001) is given below: 
• LB plate was streaked with DH5α frozen stock. 
• One good separated colony was chosen for inoculation of 3 ml liquid LB media. 
Media was incubated at 37 °C with 250 rpm shaking overnight (~16 hours). 
• 100 ml LB medium was inoculated with overnight culture, and incubated at 37 
°C with 250 rpm shaking for 2.5-3 hours until OD590 reaches 0.612 
• Culture was taken into 2 pre-chilled sterile 50 ml falcons and placed on ice for 10 
minutes. 
• Vials were centrifuged at 2500 rpm for 5 minutes at 4 °C. Supernatant was 
discarded. 
• Each pellet was washed with 10 ml ice cold CaCl2 solution, and then, centrifuged 
at 2500 rpm for 5 minutes at 4 °C. 
• Pellets were resuspended with 2 ml ice cold CaCl2 solution and 20 μl of 
resuspension aliquoted into pre-chilled 1.5 ml eppendorf tubes. Aliquots were 
frozen with liquid nitrogen and stored at -80 °C. 
And heat shock transformation was applied accordingly: 
• Aliquots were taken from -80 °C, and thawed on ice. 
• 1 μg DNA was added to each vial and left on ice for 30 minutes. 
• The vial was placed in 42 °C water bath for 45 seconds and put on ice for 2-3 
minutes. 
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• 100 μl of SOC medium was added, and then, culture was incubated at 37 °C with 
250 rpm shaking for 1 hour. 
• Cultures were plated on selective medium with appropriate antibiotic (LB-Kan) 
• Plates were incubated at 37 °C overnight. 
After incubation, recently emerged positive results were screened via colony PCR: 
• 30 μl of sterile double distilled H2O was added to adequate number of PCR 
tubes, and a tip of each colony was resuspended.    
• Mixture was boiled for 5 minutes. 
• The consequential mixture was vortexed and centrifuged. 
• Supernatant of the mixture was employed as sample to PCR reaction given in the 
table below: 
Table 2.12 Colony PCR reaction mix for pGBKT7-p60 transformed cells 
Stock Ingredients Amoun for 1X rxn mix (25 μl) 
Taq Buffer (10X) 2,5 μl (1X) 
MgCl2 (25 mM)  2 μl (2 mM) 
Forward primer (25 mM) 0.5 μl (0.5 mM) 
Reverse primer (25 mM) 0.5 μl (0.5 mM) 
dNTP (10 mM) 0.5 μl (0.2 mM) 
Taq enzyme (5u/ul) 0.2 μl (1 unit) 
Colony mixture 1 μl 
Sterile double distilled water 17.8 μl 
Total 25 μl 
 
Table 2.13 PCR program for colony PCR of pGBKT7-p60 
Initial denaturation (94 : 3 min  
Denaturation (94 °C)           : 15 sec  
Annealing (61 °C)               : 30 sec  
Extension (72 °C)                : 30 sec  
Final extension (72 °C)       : 5 min  
  
The resultant PCR products were employed on 1% TAE Agarose gel and insert 
containing colonies were selected. 
 
 
 
30 loops
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2.2.1.7. DNA Isolation 
DNA was isolated from positive colonies with Roche Miniprep DNA isolation Kit. 
The principle of the kit is as followed; alkaline lysis of bacteria, clearing RNA traces 
with RNAse, with the aid of chaotropic salt Guanidine phaosphate DNA molecules 
selectively bind to glass fleece; remains of bacterial lysate are cleared with washes 
and finally eluted with low salt buffer. The protocol of kit is given below:  
• 5 ml of LB was inoculated with positive colony and the culture was incubated at 
37 °C with 250 rpm shaking overnight. 
• Overnight cultures were centrifuged at 5000 rpm for 5 minutes. Supernatant was 
discarded and pellet was resuspended in 250 μl Suspension Buffer [50 mM Tris-
HCl, 10 mM EDTA and 0.1 g/L]. The suspension was taken into 1.5 eppendorf 
tubes. 
• 250 μl Lysis Buffer [0.2 M NaOH and 1% SDS] was added to suspension and 
mixed gently with inverting 3 to 6 times. Then mixture was incubated at RT for 5 
minutes. 
• Following 350 μl chilled Binding Buffer was added and mixed gently inverting 
the tube 3 to 6 times. Afterward, it was chilled on ice for 5 minutes. Cloudy 
mixture was resulted after chilling. 
• Mixture was centrifuged at 14000 rpm for 10 minutes in a standard table top 
centrifuge. Next, the supernatant was obtained without disturbing the pellet and 
loaded on the filter column tube. 
• The filter tube was centrifuged at 14000 rpm for 1 minute, flow-through was 
discarded. 
• 700 μl of Wash Buffer II was added to filter column and column was centrifuged 
at 14000 rpm for 1 minute. The flow-through was discarded. 
• Filter column was centrifuged an additional 1 minute and the filter was placed on 
a clean 1.5 ml eppendorf tube. 
• 50 μl Elution Buffer was added to upper reservoir of the filter tube and the set-up 
was left 1 minute on bench. 
• The tube was centrifuged at top speed for 1 minute and the concentration was 
identified with OD 260 nm (An OD260 of 1 corresponds to 50 µg/ml for double-
stranded DNA). 
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2.2.2. Transformation of Yeast 
 Constructed bait plasmid was supposed to be inserted into an appropriate mating 
type strain of S. cerevisiae on account of mating. Since commercial cDNA library is 
transformed into S. cerevisiae Mat α type Y187 strain, bait plasmid was designed to 
be introduced into S. cerevisiae Mat a type AH109 strain which is supplied with 
Clontech Pre-transformed cDNA library. Yeast do not comprise competency, 
consequently competent yeast cells are prepared prior to transformation. In 
competency of yeast cells, chemical method is also applied. AH109 yeast cells were 
altered to competent cells with LiAc/TE method which disrupts the cell wall. 
Transformation of DNA was mediated with heat shock in which holes in membrane 
structure formed. 
2.2.2.1. Competent Cell Preparation 
Competent cell preparation of yeast cells was performed with Yeastmaker 
transformation kit. The procedure of kit is given below:  
• YPDA plate was streaked with AH109 strain stock taken from -80 °C; incubated 
at 30 °C for 3-4 days. (This resultant working stock plate could be preserved for 
1 month at 4 °C). 
• 1 colony was inoculated into 3 ml of YPDA medium and incubated at 30 °C for 
8-12 hours. 
• 5 μl of culture was inoculated to 50 ml of YPDA medium and incubated until 
OD600 was between 0.15 - 0.30 (approximately 18-20 hours). 
• Cells were centrifuged at 2000 rpm for 5 minute, and supernatant was discarded. 
Pellet was suspended in 100 ml YPDA, then mixture was incubated at 30 C until 
OD600 reaches 0.4 - 0.5 (approximately 3-5 hours). 
• Culture was centrifuged at 2000 rpm for 5 minute, and supernatant was removed. 
• Pellet was dissolved in 60 ml of sterile double distilled water. 
• Solution was centrifuged at 2000 rpm for 5 minutes, supernatant was removed.  
• Cells were resuspended in 3 ml 1.1X TE/LiAc solution (1.1X TE, 110 mM LiAc) 
and cells were divided into two 1.5 ml sterile eppendorf. 
• Eppendorf tubes were centrifuged at 14000 rpm for 15 seconds.  
• Supernatant was removed and each pellet was dissolved in 600 μl 1.1 X TE/LiAc 
solutions. These mixtures may be left at room temperature for several hours. 
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2.2.2.2. Yeast Transformation  
The next step to competent cell preparation was transformation of prepared 
competent yeast cells with constructed bait plasmid. After transformation, S. 
cerevisiae AH109 Mat a strain contained DNA binding vector construct including 
human katanin p60. Transformation of yeast cells was achieved with LiAc/PEG 
Transformation protocol in YeastMaker Tranformation Kit. Protocol is given below: 
• A sterile 1.5 ml microfuge tube was prepared to contain 1 μg construct plasmid 
and 5 μl denaturated Herring Testes Carrier DNA (10mg/ml). 
• 50 μl of previously generated competent cells was added to DNA mixture and 
mixed gently. 
• 0.5 ml PEG/LiAc (%40 PEG, 1X TE, 100mM LiAc; all components were sterile) 
was added to suspension and gently mixed with inverting tube up and down. 
• The competent yeast cells and DNA suspension were incubated at 30 °C for 30 
minutes, and mixed with 10 minute intervals. 
• 20 μl DMSO was added and cells were suspended. Subsequently, the tubes were 
placed in a 42 °C water bath for 15 minutes, and mixed with 5 minute intervals. 
• Cells were centrifuged and the supernatant was discarded. Pellet was dissolved in 
1 ml sterile 0.9% NaCl solution. 
• 100 μl mixture was employed on appropriate selection medium (for pGBKT7 
plasmid, it was SD/-Trp) and plates were incubated at 30 °C for 3-6 days. 
• After colonies emerge, plates were sealed and stored at 4 °C (no longer than 1 
month) as working stock.  
2.2.3. Generation of Diploid Cells 
S. cerevisiae mating strains AH109 and Y187, containing respectively pGBKT7 and 
pACT2 plasmids were mated in order to place two yeast expression vectors in same 
yeast diploid organism.  
2.2.3.1. Yeast Mating     
• One colony from yeast transformation plate of our construct plasmid was seeded 
to 50 ml SD/-Trp. 
• Culture was incubated at 30 °C, with 250 rpm shaking until the OD600 reaches 
0.8. 
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• Cells were centrifuged at 1500 rpm for 5 minutes. Supernatant was discarded and 
the cells were dissolved in the residual liquid (~5ml). 
• One aliquot of cDNA library (human fetal brain cDNA library in pACT2 at 
Y187) was thawed (10 μl of pretransformed library was separated in a separate 
vial for library control). 
• AH109 bait culture and Y187 cDNA library were mixed entirely in a 2 L sterile 
flask, with 50 mL 2X YPDA/Kan. 
• Culture was incubated at 30 °C overnight (20-24 hours) with 30-50 rpm shaking. 
• Cells were centrifuged at 1500 rpm for 10 minutes; and supernatant was 
removed. 
•  2L flask was washed 2 times with 50 ml 2X YPDA/Kan and pellet was washed  
with these flask wash liquids. 
•  Cells were centrifuged  at 1500 rpm for 10 minutes and the pellet was 
resuspended with 10 ml 0.5X YPDA/Kan. 
• Mating suspension was plated on ~180 SD/-his/-leu/-trp triple drop-out plates 
(less stringent), and a series of dilution (1/10, 1/100, 1/1000, 1/10000) were 
plated on SD/-Leu, SD/-Trp and SD/-Leu/-Trp for calculating mating efficiency. 
• Plates were incubated at 30 °C for 4-5 days until colonies emerge. 
2.2.3.2. Increasing Stringency for Diploid Selection 
Less stringent media was selected for the first inoculation of diploid cells. Since the 
mating media is an extensively nutrient-full media, high stringency may lead the 
death of some proportion of diploid cells. However, after surviving in less stringent 
media, stringency should be increased in order to obtain less false positive results at 
the end. For this purpose, mating plates were transferred to SD/-ade/-his/-leu/-trp, 
quadruple drop-out plate (SD QDO) plates with replica plate method.    
The protocol for replica plate is given below: 
• A sterile velvet cloth was placed and fixed on the block of replica plate 
apparatus. 
• SD TDO mating plate was placed and pressed on the sterile velvet cloth with an 
even pressure and dissembled from replica apparatus. 
• A SD QDO was placed on velvet having cell pattern of previous plate and evenly 
pressed. 
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2.2.4. Diploid Cell Phenotype Confirmation 
2.2.4.1. Multiple Streaks 
Cells growing on SD QDO media plate were further streaked again onto SD QDO 
plates in order to decrease the number of multiple activation domain bearing 
plasmids. Each colony was streaked separately and streaking procedure is continued 
until fifteenth streaks. 
2.2.4.1. Colony lift assay 
In order to obtain genuine positive results, all selectivity experiments were 
performed on diploid cells. GAL4 system, in our experimental design, has three 
genes downstream, two of these three are essential amino acid genes and used in 
nutrient selection medium. Third one is MEL1 which is expressing α and β 
galactosidase. In colony lift assay, diploid cell were investigated for their ability to 
utilize β galactose. 
 
• Fresh colonies (grown at 30°C for 2–4 days), 1–3 mm in diameter were used for 
this experiment. 
• Z buffer/X-gal solution was prepared just before the assay. 
• For each plate of transformants to be assayed, a sterile Whatman No. 5 filter was 
presoaked by placing it in 2.5–5 ml of Z buffer/X-gal solution in a clean 100- or 
150-mm plate.  
• Using forceps, a clean, dry filter was placed over the surface of the plate of 
colonies to be assayed. The filter was gently rubbed with the side of the forceps 
to help colonies cling to the filter. 
• Holes were poked through the filter into the agar in three or more asymmetric 
locations to orient the filter to the agar. 
•  When the filter had been evenly wetted, it was carefully lifted off the agar plate 
with forceps and transferred (colonies facing up) to a pool of liquid nitrogen. 
Using the forceps, the filters were completely submerged for 10 seconds. 
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•  After the filter has frozen completely (~10 seconds), it was moved from the 
liquid nitrogen and allowed to thaw at room temperature. (This freeze/thaw 
treatment was to permeabilizes the cells.) 
• The filter was carefully placed, colony side up, on the presoaked filter. Trapping 
air bubbles under or between the filters was avoided. 
• The filters were incubated at 30°C (or room temperature) and checked 
periodically for the appearance of blue colonies. 
2.2.5. Plasmid Selection 
There is a high number of interacting diploids in yeast two hybrid studies; isolating 
plasmids from each clone is laborious and expensive. Therefore, the decision on 
which plasmid is going to be isolated was made by yeast colony PCR and subsequent 
restriction enzyme digestion for fingerprinting. 
2.2.5.1. Yeast Colony PCR 
Yeast colony PCR was executed with pACT2 amplification primers. Procedure of 
yeast colony PCR is given below: 
  
• 30 μl of sterile double distilled H2O was added to adequate number of PCR tubes, 
and a tip of each colony was resuspended.    
• Mixture was boiled for 15 minutes. 
• The consequential mixture was vortexed and centrifuged. 
• Supernatant of the mixture was employed as sample to PCR reaction given 
below: 
Table 2.14 Yeast Colony PCR constituents  
Stock Ingredients Amount for 1X rxn mix (25 ul) 
Taq Buffer (10X) 2,5 ul (1X) 
MgCl2 (25 mM)  2 ul (2 mM) 
Forward primer (25 mM) 0.5 ul (0.5 mM) 
Reverse primer (25 mM) 0.5 ul (0.5 mM) 
dNTP (10 mM) 0.5 ul (0.2 mM) 
Taq enzyme (5u/ul) 0.2 ul (1 unit) 
Colony +water mix 18.8 μl 
Total 25 μl 
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Table 2.15 PCR Program for Yeast Colony PCR 
Initial denaturation (94 °C) : 3  
Denaturation (94 °C)        : 15 sec  
Annealing (61 °C)            : 30 sec  
Extension (72 °C)             : 30 sec  
Final extension (72 °C)     : 5 min  
 
PCR products were applied on 1% TAE gel in order to identify if there are more than 
one product for plasmid primers. One product containing samples were selected and 
digested with frequent cutter AluI enzyme for fingerprinting, and fragments were 
applied on 2% TAE agarose gel. Same restriction pattern containing diploids are 
determined as same proteins, so diploids with different pattern are chosen in order to 
isolate plasmid DNA.  
2.2.5.2. DNA Isolation 
After plasmids were selected through yeast colony PCR and AluI digestion pattern, 
DNA isolation was performed. Yeast cells comprise a thick cell wall; hence general 
use bacterial plasmid isolation kits can not be applied. Thus, cells were pre-treated 
with lyticase which disrupts the chemical bond between cell wall components. These 
pre-treated cells were employed to Qiaprep Spin Miniprep. Pre-treatment protocol of 
yeast cells is given below:  
 Each colony was seeded to 5 ml SD/-ade/his/-leu/-trp medium in a glass tube, 
and incubated at 30 °C for 24 hours. 
 Cells were centrifuged at 4000 rpm for 10 minutes. 
 The supernatant was discarded and the pellet was dissolved in residual SD media, 
the culture was transferred into 1.5 ml microcentrifuge tubes. 
 10 μl lyticase was added and mixture was incubated at 30 °C for 1 hour 
(alternatively 100 μl of 450 μm diameter glass beads were used and vortexed 
thoroughly for 10 minutes.) 
 After incubation, the mixture was applied in Qiaprep Spin Miniprep Plasmid 
Isolation Kit.  
Qiaprep Spin Miniprep Plasmid Isolation Kit is also working with same principal as 
Roche Plasmid Kit. Procedure is given below: 
• Pre-treated yeast cells were mixed with 250 μl Buffer P1 and transfer to a 
microcentrifuge tube. 
30 loops
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• 250 μl Buffer P2 was added and mixed thoroughly by inverting the tube 4–6 
times. 
• 350 μl Buffer N3 was added and mixed immediately and thoroughly by inverting 
the tube 4–6 times. 
• Suspension was centrifuged for 10 minutes at 14,000 rpm in a table-top 
microcentrifuge. 
• The supernatant from previous step was applied to the QIAprep spin column by 
decanting or pipetting. 
• Filter-tube assambly was centrifuge for 30–60 seconds. The flow-through was 
discarded. 
• The QIAprep spin column was washed by adding 0.5 ml Buffer PB and 
centrifuging for 30–60 seconds. Flow-through was discarded. 
• The QIAprep spin column was washed by adding 0.75 ml Buffer PE and 
centrifuging for 30–60 seconds. 
• The flow-through was discarded, and tubes were centrifuged for an additional 1 
minute to remove residual wash buffer. 
• QIAprep column was placed in a clean 1.5 ml microcentrifuge tube. To elute 
DNA, 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) was added to the center of each 
QIAprep spin column. Column was let standing for 1 minute, and centrifuged for 
1 minute. 
Plasmids isolated from diploid cells are a mixture of plasmids, it contains both bait 
and prey plasmids as well. The concentration of yeast isolated DNA is very low. 
Therefore, 10 μl of plasmid was transformed into competent E. coli DH5α strain in 
order to increase the number of prey plasmids to be isolated. Transformations were 
selected with ampicillin resistance which is conferred to pACT2. DNA isolations 
were performed with Roche High Pure Plasmid Kit as emphasized in section 2.2.1.6. 
2.2.6. Co-transformation 
Since yeast-two-hybrid technique results in many false positive interactions, there are 
control experiments as co-transformation in order to decrease the number of false 
positives. In this experiment design, each prey plasmid was co-transformed for 2 
times; one with bait plasmid containing p60, one with empty bait plasmid (Fig. 2.3). 
100 ng of each plasmid was transformed with LiAc Transformation - enlightened in 
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2.2.2.2. -, and then each transformation was plated on SD double drop-out and SD 
quadruple drop-out plates. 
 
Figure 2.3 Illustration of cotransformation experiment set-up 
2.2.7. Sequencing  
After cotransformation, a list of possible interaction plasmids was in our hands.  The 
identification of the cDNA inserted into prey plasmids was performed by 
sequencing. 
2.2.7.1. Sequencing PCR 
Sequencing PCR is special kind of PCR in which single strand of DNA is amplified. 
Each dNTP is labeled with different fluorescent tag; therefore, resultant DNA 
fragment is fluorescently labeled. Single strand of DNA is desired to be exploited 
since 2 strands apparently interfere the fluorescence of each other. Thus, only one 
primer is used in Sequencing PCR. All ingredients are placed on ice and reaction is 
performed in dark in order to preserve fluorescence. The reaction mixture 
preparation is given in the table below: 
Table 2.16 Sequencing PCR ingredients 
Stock Ingredients Amounts for 1X rxn mix (10 μl) 
Big dye sequencing buffer 2 μl (1X) 
Big dye 2 μl 
Reverse primer / Forward primer 0.5 μl  
Template DNA 1 μg 
Sterile mq water 3.5 μl 
Total 10 μl 
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Table 2.17 Sequence PCR program 
Initial denaturation (94 °C)  : 3 min  
Denaturation (94 °C)           : 15 sec  
Annealing (55 °C)               :  15 sec  
Extension (68 °C)               :  1 min  
Final extension (68 °C)        : 5 min  
 
2.2.7.2. PCR Product Purification for Sequencing 
Since PCR product was contaminated with polymerase, a subsequent purification 
was performed. The protocol is given below: 
• 10 μl PCR product was taken in to microfuge tube; then, 2μl of 3M NaAc and 
50 μl ice-cold 95% ethanol were added to tube. 
• Tubes were incubated on ice for 30 minutes. 
• Mixture was centrifuged at 14000 rpm for 15 minutes. Supernatant was 
discarded and pellet was resuspended in ice-cold %70 ethanol. 
• Tubes were centrifuged at 14000 rpm for 15 minutes. Supernatant was 
discarded. 
• Tubes were incubated at 95°C for 5 minutes with caps open (in order to 
evaporate ethanol) 
• 20 μl of formamide was added to DNA pellet and the mixture was vortexed 
vigorously  
• Tubes were again incubated at 95 °C for 5 minutes with caps closed 
• Tubes were immediately put on ice and kept at 4 °C until analysis. 
2.2.7.3. Analysis of Sequence Results 
Analysis of sequence results was performed with NCBI Blast program (internet 
address, http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). Highly related sequences 
matching to sequence query were displayed from nucleotide databank.  
40 loops
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3. RESULTS 
3.1. Bait Plasmid Construction 
Katanin p60 cDNA was present as inserted into pEGFP-C1. Primers were designed 
to specifically amplify p60 cDNA and comprise flanking regions containing 
restriction enzyme digestion sites of SalI and XmaI. p60 cDNA was sub-cloned into 
same open reading frame after DNA binding domain of GAL4 transcription factor 
with the aid of primers. Primers were designed according to Homo sapiens katanin 
p60 mRNA coding sequence, sequence data was taken from 
http://www.ncbi.nih.gov/ NM_007044. PCR amplification of katanin p60 with 
designed primers successfully resulted in ~1550 bp product (Fig. 3.1). 
 
Figure 3.1 PCR was performed to clone p60 (Lane 1: Fermentas Mass Ruler Mix 
DNA Marker, Lane 2 and 3: p60 PCR products) 
Amplified cDNA was designed to be inserted into Clontech pGBKT7 DNA BD 
vector with restriction enzymes of SalI and XmaI. Therefore cDNA and the vector 
were restricted with Fermentas Cfr9I(XmaI) and SalI enzymes (Fig. 3.2).  
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 39 
 
 
 
 
 
 
Figure 3.2 Multiple Cloning Site map for pGBKT7 vector, restriction sites are 
marked with arrows. 
Restricted DNA fragments were purified with Roche High Pure PCR Product Kit and 
ligation procedure was performed with Roche T4 DNA ligase. Subsequently, ligation 
mixture was transformed to CaCl2 treated E. coli DH5α cells. Since plasmid DNA 
included replication origin of E. coli, plasmid DNA was able to replicate in 
transformed E. coli cells. Copy number of plasmid DNA was improved with 
transformation. In order to verify accuracy, transformed colonies including katanin 
p60 cDNA were examined with colony PCR using pGBKT7 insert amplification 
primers. Five colonies were analyzed by PCR, and gel photo (Fig. 3.3) confirmed 
that all of them contained pGBKT7 with p60 cDNA inserted. 
 
Figure 3.3 Colony PCR results for five pGBKT7-p60 transformed colonies 
After verification of colonies including pGBKT7 with p60 cDNA, one of the 
colonies was selected and plasmid purification procedure was performed to isolate 
plasmids. Purified plasmid DNA was subjected to subsequent analysis to identify 
whether cDNA was inserted into plasmid correctly. Restriction digestion with 
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Table 3.1 Control plate scores 
 SD-Leu SD-Trp SD-Leu-Trp 
1/10000 2 Uncountable  1 
1/1000 9 Uncountable 1 
1/100 68 Uncountable 7 
1/10 890 Uncountable  78 
 
3.2.1. Mating Calculations 
Since mating results required quantification, control plate scores were used for 
further calculations. Number of colony forming units (Cfu) for each plate was 
calculated. Mating efficiency was determined by the ratio of mated diploid clones to 
limiting mating partner. Considering this mating experiment, limiting partner was 
cDNA library pACT2 containing yeast cells. Since the other partner pGBKT7-p60 
containing cells grew extensively, score was uncountable.  
3.2.1.1. Calculating Number of Cfu per Milliliter  
The formula for calculation of Cfu per milliliter is given below: 
݊ݑܾ݉݁ݎ݋݂ ݂ܿݑ ݌݁ݎ ݈݉ ൌ
number of cfu x 1000 μl/ml
volume plated ሺμlሻx Dilution factor
 ሺ3.1ሻ  
According to SD – Leu control plate scores, number of cfu/ml of pACT2-cDNA 
library containing yeast cells was calculated as given below: 
 
2 x 1000 μl/ml
100 μl x 10ିସ
ൌ 2 ݔ 10ହ 
9 x 1000 μl/ml
100 μl x 10ିଷ
ൌ 9 ݔ 10ସ 
68 x 1000 μl/ml
100 μl x 10ିଶ
ൌ 6.8 ݔ 10ସ 
890 x 1000 μl/ml
100 μl x 10ିଵ
ൌ 8.9 ݔ 10ସ 
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The mean of results was calculated; 1.12 x 105 colonies having pACT2 plasmid were 
present in 1 ml of mating mixture. 
According to SD –Leu/ -Trp contol plate score, number of cfu/ml of Diploid colonies 
having both pACT2 and pGBKT7 was calculated as given below: 
 
1 x 1000 μl/ml
100 μl x 10ିସ
ൌ 10ହ 
1 x 1000 μl/ml
100 μl x 10ିଷ
ൌ 10ସ 
7 x 1000 μl/ml
100 μl x 10ିଶ
ൌ 7 ݔ 10ଷ 
78 x 1000 μl/ml
100 μl x 10ିଵ
ൌ 7.8 ݔ 10ଷ 
The mean of four diploid control plates was calculated to be 3.12 x 104; therefore, 
3.12 x 104 colonies present in 1 ml of mating mixture. 
3.2.1.2. Mating efficiency 
݉ܽݐ݅݊݃ ݂݂݁݅ܿ݅݁݊ܿݕ ൌ
Number of diploid cells in the mixture
number of cells of limiting partner
ሺ3.2ሻ  
 
3.12 x 10ସ
1.12 x 10ହ
 x 100 ൌ 30 %  
30 % percent of mating efficiency was obtained. Mating efficiency should be greater 
than 5 % as stated in manufacturer manual.  
3.2.1.3. Number of screened clones 
݊ݑܾ݉݁ݎ ݋݂ ݈ܿ݋݊݁ݏ ݏܿݎ݁݁݊݁݀
ൌ ݊ݑܾ݉݁ݎ ݋݂ ݂ܿݑ ݀݅݌݈݋݅݀ ݔ ݏݑݏ݌݁݊ݏ݅݋݊ ݒ݋݈ݑ݉݁ሺ3.3ሻ  
23800 ൌ 3.12 ݔ 10ଷ ݔ 7.5 
When we calculated the number of clones screened in mating experiment, 23800 
clones were shown to be examined. 
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After evaluation of mating score calculations, we concluded that mating experiment 
was executed efficiently. 
3.2.2. Replica Plate 
Subsequent to plating mating mixture on SD –His –Leu –Trp plates, the stringency 
of the experiment was increased one step forward to SD –Ade –His –Leu –Trp 
plates. SD –His –Leu –Trp plates were replicated onto SD –Ade –His –Leu –Trp 
plates. In the first stringency level ~3000 clones were present in the SD Triple drop-
out plates. ~2000 clones were remained after replica plating.  
 
Figure 3.5 Representative display of replica plates. (1. Mating Plate 55 SD –His –
Leu –Trp, 2. Replica of Mating plate 55 SD –Ade –His –Leu –Trp, 3. Mating Plate 
56 SD –His –Leu –Trp, 4. Replica of Mating Plate 56 SD –Ade –His –Leu –Trp) 
3.2.3. Multiple Streaks and Plasmid Selection 
Multiple streaks were performed for 15 times and 121 clones survived at the end of 
the procedure. Before plasmid DNA was isolated from yeast cells, colony PCR was 
employed to screen diploid cells to clarify whether they contained more than one 
activation domain plasmid. 75 of these diploid clones were chosen according to 
colony PCR results. 
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Figure 3.6 Colony PCR results (Lanes were loaded  in order, except Fermantas Mass 
Ruler Mix was loaded in the middle of each row) 
3.3. Co-transformation 
Plasmid DNA of activation domain plasmids was isolated from diploid cells. The 
next step was confirming whether the interaction between bait and cDNA protein 
was genuine. Co-transformation eliminated the false positives results from yeast two 
hybrid screens. 38 diploids were proven to be genuine positives from 75 plasmids. 
These genuine positive plasmids were later sequenced to identify cDNA in pACT2 
vector. 
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Figure 3.7 Representative genuine positive co-transformation result (1. Colony # 60 co-transformed 
with empty pGBKT7 on SD –Leu –Trp plate, 2. Colony co-transformed with empty pGBKT7 on SD –
Ade –His –Leu –Trp, 3. Colony # 60 co-transformed with pGBKT7-p60 on SD –Leu –Trp, 4. Colony 
# 60 co-transformed with pGBKT7-p60 on SD –Ade –His –Leu –Trp) 
3.4. Sequence Alignment Analysis 
3.4.1. Sequence Data Mining 
cDNA sequences of genuine positive plasmids were aligned via NCBI Blast Tool. 
Results are given in Appendix. 
3.4.2. Sequence Alignment Results 
Sequence alignment results indicated following proteins. Brief descriptions of 
proteins are given below:  
• NADH dehydrogenase (ubiquinone) 1 beta complex 6 is a polypeptide that 
constitutes in first enzyme complex in electron transport chain of 
mitochondria (Smeitink et al., 1998). 
• Rho-related Broad Complex, Tramtrack, and Bric-a-brac (BTB) domain 
containing 3 is a member of the rho BTB subfamily of Rho-GTPase which is 
abundant in neural system (Ramos et al., 2002). 
•  Chondroitin polymerizing factor (CHPF) is a transmembrane 
glycosyltansferase enzyme (Kitagawa et al., 2003).  
31 
2  4
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•  Rho-guanine nucleotide exchange factor stimulates the exchange of guanyl 
nucleotides by GTPase of Rho family. This protein is prevalently present in 
neural system and its intracellular localization is neurite outgrowth zones and 
nucleus (Meyer et al., 1999). 
• Glucose-6-phosphate dehydrogenase is a cytosolic protein takes role in 
pentose phosphate pathway and it is a housekeeping gene (Luzzatto and 
Afolayan, 1968). 
• Myeloid leukemia factor 2 : Myeloid leukemias with various cytogenetic 
abnormalities, failed to reveal MLF2 gene rearrangements (Kuefer et al., 
1996) 
• Leukocyte receptor cluster member 8 interacts with telomeric motor neuron 
survival factor 1 (Liu and Dreyfuss, 1996) and homeo box protein PEPP 
subfamily 2, a transcription factor (Rual et al., 2005) where both related 
proteins distinctively interacting with nuclear RNA activating complexes.  
• Small nuclear RNA activating complex, SNAPC4 recognizes RNA 
polymerase II and III snRNA promoters and initiate basal levels of 
transcription and functions as transcription factor (Wong et al., 1998)   
• Src homology 3 (SH3) domain growth factor receptor bound protein 2 
(GRB2)-like endophilin B2 is hypothesized as link between Bax and 
cytoskeleton elements (Benoit et al., 2001). 
• Septin 3 takes role in neuronal differentiation (Methner et al., 2001).  
• Tubulin beta is constituent of microtubules. Microtubules are extensively 
described in section 1.1.2. 
• Meteorin plays important roles in both glial cell differentiation and axonal 
network formation during neurogenesis (Nishino et al. 2004).  
• Actin beta is a cytoskeletal protein. Polymerization of actin beta monomers 
generates actin filament (F-actin) (Alberts et al., 2003). 
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• Zinc finger family member 767 is a zinc finger motif containing protein 
(Strausberg et al., 2002).  
• Solute carrier family 44, member 2 : Choline transporter like protein 2 
(CTL2) contains multi-trans-membrane domain. This protein takes role in 
activation of NfκB cascade (Matsuda et al., 2003) and hearing (Nair et al., 
2004).  
• KIAA1853 protein; is a medullablastoma tumor antigen(Behrends et al., 
2003). 
• Wiskott-Aldrich syndrome (WAS) protein family member 2 involved in 
Actin cytoskeleton organization cascade under rho GTPases (Bear et al., 
1998).  
• Carboydrate sulfotransferase is a membrane integrated protein and it 
possesses a role in central nervous system in pituitary gland (Hiraoka et al., 
2001) and interacts with chondroitin modifying enzymes. 
• Calcium binding protein 22 pseudogene (Calcineurin B homologous protein, 
CHP) is EF-hand Calcium binding protein binds microtubule (Timm et al., 
1999) and takes role in neuron growth cone pathway.  
• Regulator of G protein signaling 11 is a GTPase activator in intracellular 
signaling cascade so controls the activity and fidelity of G protein β (Snaw et 
al., 1998).   
• Chromosome 6 contig fragment  
• Chromosome 9 open reading frame 127 
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4. DISCUSSION 
4.1. Yeast cultivation 
Cultivation of yeast cells was performed with appropriate selection medium at 30 °C. 
Initially, incubation of yeast cultures was performed in falcon tubes as stated in 
Clontech Pre-transformed cDNA library manual. Apparently, cultures did not grow 
even after 3 days of incubation at 30 °C.  
Since aged cultures are possibly lost their plasmids, our diploid cell inoculums might 
also have lost their plasmids. In order to detect whether inoculums used in yeast 
cultivation caused this problem, renewal of diploid cells was performed via streaking 
on SD QDO and renewed diploid cells were inoculated into appropriate selection 
medium. However, this troubleshooting trial did not work; cell growth was not 
observed with the renewed inoculums either. The second trial was done by culturing 
yeast cells in glass tubes, and actually the cultivation problem was solved with this 
approach. One can conclude that yeast cells prefer to grow in glass, rather than 
polypropylene falcon tubes.  
4.2. Transformation of DNA isolated from yeast 
Following the isolation of pACT2 activation domain vector with interacting cDNA 
from yeast, transformation of E. coli DH5α with newly isolated DNA was performed 
in order to increase the amount of plasmid. However, efficiency of these 
transformations was inadequate; for instance 1 or 2 colonies per transformation was 
observed.  
For this impairment, trasformation efficiency of E. coli XL 1 blue cells was also 
examined besides E. coli DH5α. Yet, this approach did not solve the problem. The 
efficiency was in the same range as previous experiments, and also the organism was 
a slow growing E. coli strain. Consequently, study continued with the previous 
organism, E. coli DH5α.  
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Since competent cells loose their viability up to some extent while freezing; 
preparing fresh batch of competent cells for each transformation was considered. 
Preparation of fresh competent cell worked efficiently. 
4.3. Co-transformation 
Co-transformation experiments were performed to eliminate false positive results. 
Candidate plasmid was co-transformed with empty and bait containing DNA binding 
domain vector and each co-transformation was examined separately in synthetic 
medium lacking tryptophan, leucine (SD DDO) and lacking adenine, histidine, 
tryptophan, leucine (SD QDO). Experimentally, although growth of SD DDO plate 
was present extensively, growth in SD QDO plate was not observed. This pattern 
was present on large number of plates; as a result co-transformation was not working 
properly.  
After examination of co-transformation protocol, plating yeast cells on SD QDO 
after co-transformation was thought to be exceptionally harsh. The cells were plated 
immediately after co-transformation where their stability and integrity were changed. 
In addition, yeast cells had to express reporter gene products on SD QDO medium. 
Probably, cells did not survive during the time required for reporter gene expression. 
The resultant colonies of SD DDO co-transformation was subsequently streaked on 
SD QDO plate, and finally this procedure solved co-transformation problem.  
 
 
Figure 4.1 Co-transformation representative streak (2 plates in top are SD DDO 
plates and streaked on SD QDO respectively)  
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In addition, cells could be cultivated in nutrient rich medium for a short time after 
co-transformation and then these cells could be plated onto an appropriate nutrient 
selective media as frequently used in E.coli heat transformation protocols.   
4.4. Sequencing Results 
22 sequences were identified, where some sequence results were eliminated due to 
poor resolution in sequencing. There are 19 novel interactions found for katanin p60. 
Although the interactions should be proved with methods besides Yeast Two Hybrid 
technique, the results are highly promising. 
1 of 22 results was tubulin which was shown to intact with katanin p60 (detailed 
information is given in the next page). 2 of 22 results did not comprise any product. 1 
was a part of chromosome 6 genomic contig. While producing cDNA libraries, it is 
possible to end up with a small portion of genomic DNA contamination. Since Yeast 
Two Hybrid is a fishing experiment, this genomic contig could be pulled from such a 
genomic DNA contamination. The other result was part of an open reading frame in 
chromosome 9, which does not express any protein or product. 
Brief information about interacting proteins has already given in the result section. A 
schematic representation (Fig. 4.2) of their interaction with each other is given 
below: 
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Figure 4.2 Schematic display of interface between katanin p60 interactions. Rectangles are katanin 
interacting proteins and triangles are secondary protein interactions. Blue arrows illustrate direct 
interactions, red arrows illustrate interpreted interactions. Dotted arrows illustrate interaction with 
secondary proteins.     
Tubulin beta is a subunit of tubulin heterodimer which builds microtubules thus its 
interaction with microtubules is expected. However, in the experiment only beta 
subunit of tubulin heterodimer was identified as interacting with katanin p60. This 
can lead us to a conclusion that katanin p60 possibly binds microtubules via tubulin 
beta subunits. However, tubulin alpha may not be selected because of elimination 
during selection processes or this protein is a false negative. Additionally, only one 
third of cDNA clones are integrated accurately into activation domain vector hence 
employed cDNA library may not contain tubulin alpha. Nevertheless, tubulin beta 
and katanin p60 interaction also confirmed accuracy of the Yeast Two Hybrid 
technique which was used for the first time in our lab. 
Actin beta is a monomer in actin cytoskeleton. Previously, katanin has not been 
found to interact with actin filament. However, interaction of katanin with actin 
filaments is possible since the katanin is present in axonal outgrowth regions (Yu et 
al., 2008) and actin filaments are also enriched in newly forming axon branches. 
Septin 3 is a brain specific protein, and it forms filaments in non-mitotic cells 
associated with strongly either with tubulin (Surka et al., 2002) or actin network 
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(Kinoshita et al., 1997). Moreover, in some cases it is associated with both networks 
(Surka et al., 2002). Septin 3 takes role in vesicle trafficking, neurite outgrowth and 
neurofibrillary tangle formation (Methner et al. 2001). According to the properties of 
septin 3, its interaction with katanin p60 seems to be possible. Since katanin p60 
provides motile microtubules to newly forming axon branches via microtubule 
severing (Karabay et al., 2004), interaction between these two proteins may regulate 
the microtubule severing signal of katanin p60. Septin 3 is also considered to be 
involved in leukemia, since its genomic orientation is located at a chromosomal hot 
spot for translocations in leukemia (Methner et al., 2001). A microtubule 
destabilizing protein op18/stathmin was also shown to be overexpressed in leukemia 
(Hanash et al., 1988). Microtubule severing by katanin p60 could also destruct 
microtubule organization in cell cycle dynamics of leukocyte. 
WAS protein family member 2 is a downstream effector in actin cytoskeleton 
regulatory pathway. This protein takes signal from tyrosine kinase or Rho small 
GTPases and conducts it to actin cytoskeleton. In this study, we have also shown that 
actin was interacting with katanin p60, WASF2 might also interact with katanin p60 
in order to conduct received signal to actin cytoskeleton elements. 
Meteorin is a secreted protein that acts as autocrine activator of glial cell 
differentiation and axonal outgrowth (Nishino et al., 2002). Since it is a secreted 
protein, interaction with katanin p60 could seem to be irrelevant. However, this 
protein might be internalized in neurons by endocytosis. Moreover, there might be 
different mRNA splice forms displacing the secretion signal and meteorin could act 
as an intracellular axonal outgrowth agent. 
Calcium binding protein 22 (CHP) is an EF-hand calcium binding protein and 
interacts directly with tubulin in the presence of N-myristoylation (Timms et 
al.,1999). It also interacts with Kif1Bbeta2 motor protein (Nakamura et al., 2002). 
Moreover, this protein has a role in axon guidance in neuron growth cone formation.  
Interaction of katanin p60 with this protein could be due to the tubulin binding 
property of CHP. CHP might conduct the growth cone formation signal to katanin 
p60, and this intearaction might result in microtubule severing. Additionally, this 
interaction might enhance the access of katanin p60 to microtubules. 
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Rho related BTB domain containing 3, is a small Rho GTPase. Rho GTPases are 
responsible for converting and amplifying the external signals into cellular effects, 
they are responsible for F-actin polymerization, cell proliferation, survival, 
differentiation, adhesion, secretion (Boureux et al., 2007). Rho related BTB3 is 
abundant in neuronal cells (Ramos et al., 2002). Small Rho GTPases are conductors 
of extracellular signal, and katanin might be one of their effector proteins. 
Furthermore, this protein could be responsible for GTP turnover in catalytic site of 
katanin p60.    
Rho-guanine exchange factor is a neuronal abundant exchanger protein. It was 
shown that this protein is abundant in neurites (Meyer et al., 1999). Thus, interaction 
between katanin and rho-guanine exchange factor seems to be relevant. This protein 
also could be involved in GTP turnover in neurites where katanin p60 functions. 
Choline transporter like protein 2 is also an interesting match for katanin. This 
protein is involved in NFκB signaling cascade. Since a katanin p60 ortholog, 
lipotransin, is specified as functioning in hormonal regulated lipolysis (Syu and 
Saltiel, 1999), this interaction could be interpreted as involvement of katanin p60 in 
lipid metabolism. Moreover, this match might be pulled due to the homology 
between lipotransin and katanin since AAA proteins tend to form multimeric 
structures. 
Carbohydrate (N-acetylglucosamine 4-O) sulfotransferase 8 is a membrane 
integrated protein executing the sulphate transfer activity to N-acetylglucosamine. 
This protein is characterized in modification of hormones pituitary gland of central 
nervous system (Xia et al., 2000).  Interaction with chondroitin modifying enzymes 
was already verified (Hiraoka et al., 2001). Katanin p60 was also demonstrated to 
interact with Chondroitin polymerization factor which is a trans-membrane 
glycosyltransferase. In the light of these two interactions, it can be speculated that 
katanin p60 may be modified by these proteins. 
SH3-domain GBR2 like endophilin B1 was found via Yeast Two Hybrid assay with 
bait Bax, an apoptotic effector. Researchers interpreted that this protein could be link 
between Bax protein and cytoskeletal proteins (Benoit et al., 2001). Bax protein 
might conduct its apoptotic signal to microtubules via interaction of SH3-domain 
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GBR2 like endophilin B1 with katanin p60. Hence, p60 might be responsible of 
microtubule rearrangements in apoptosis. 
Regulator of G protein Signaling 11, is a GTPase activator functioning in 
intracellular signaling cascade. This protein is responsible from the G protein β 
fidelity via GTPase activation property (Snow et al., 1999). Katanin may be involved 
in G protein signaling cascade. However, this interaction may be fished due to 
homology between GTPase domain and AAA domain, since katanin p60 has an ATP 
hydrolysis functioning AAA domain. 
NADH dehydrogenase (ubiquinone) complex 1 polypeptide 6 is a nuclear coded 
mitochondrial protein which functions in the first enzyme complex in electron 
transport chain. This protein might interact with other AAA superfamily members 
and interaction with katanin p60 could take place due to its homology with AAA 
super family. Hence, this interaction is considered to be false positive.  
Glucose-6 phosphate dehydrogenase is a cytosolic housekeeper protein, and takes a 
role in pentose phosphate pathway. Interaction with katanin p60 can occur due to 
tendency of AAA superfamily members to form multimeric structure. Hence, this 
interaction may be also considered to be false positive. 
SNAPC4 is a transcription factor and required for transcription of snRNA by RNA 
polymerase I and III (Henry et al 1995). Since they are present in different 
compartments of the cell, interaction does not occur normally. Hence, this interaction 
might be considered as false positive due to AAA superfamily homology. 
Leukocyte receptor cluster member 8 is a transmembrane protein and function of 
protein is unknown. On the other hand, this protein is shown to interact with survival 
of motor neuron factor 1 (Rual et al., 2005) which has a role in neurogenesis.  
Myeloid leukemia factor 2 is involved in leukemia. These two proteins could be 
fished from myeloid ancestral glial cells. Since we identified interaction of katanin 
p60 with 3 different leukemia related proteins (with septin 3), maybe katanin has a 
function in microtubule rearrangements of disease mechanism of leukemia. 
As mentioned above, many interesting interactions of katanin are discovered. These 
interactions may be classified under six categories: 
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• Structural interactions are with tubulin and actin monomers which constitute 
cytoskeleton in neurons.  
• Interactions modulating axonal growth are with tubulin, actin, septin3, WAS 
protein family member 2, Rho GTPase BTB3, and Calcium binding protein 
22. These interactions are candidate for participating in katanin microtubule 
severing cascade. 
• Modification interactions of katanin are found to be with chondroitin 
polymerase and carbohydrate sulfotransferase. These two proteins have also 
been found to be interacting with each other. Since oligomerization pattern of 
katanin is still unknown, it is possible that katanin p60 is modified to generate 
hexameric structure. 
• Another category is committed to GTP turnover containing Rho guanine 
exchange factor and RhoGTPase BTB3. Since many tubulin-GDP 
heterodimers are generated in the action site of katanin, turnover of tubulin 
monomer may be fulfilled by these proteins. Also, since katanin p60 requires 
ATP for its activity, these proteins may participate in acquiring nucleoside 
triphosphate to its activity site.  
• Another interesting category is leukemia related proteins. This category could 
be emerged due to presence of myeloid ancestral glial cells in whole fetal 
brain. Additionally, op18 which is another microtubule destabilizing protein 
was discovered to be involved in leukemia. It could be speculated that 
microtubule severing also involves in cell cycle dynamics of leukocytes. 
• Finally, there is apoptosis category constituted by SH3 domain GRB2-like 
endophilin B2. This protein was discovered while Bax interacting proteins 
were screened with Yeast Two Hybrid method. It is speculated that this 
protein is responsible from conducting the Bax apoptosis signal to 
microtubules and actin filaments. Katanin p60 is also candidate for 
transduction of apoptosis signal because of its microtubule severing feature. 
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5. CONCLUSION AND FURTHER COMMENTS 
Yeast Two Hybrid stage of katanin p60 interaction study was thoroughly completed. 
22 protein interactions with katanin p60 were discovered by exploiting Yeast Two 
Hybrid Method. Most of the interacting proteins are promising in order to explain 
action cascade of katanin. 
However, mammalian cells have different post transcriptional modification system 
than yeast cells. Therefore, these promising interactions should be confirmed by 
further analysis with mammalian expression. 
For this purpose, mammalian expression and coimmunoprecipitation experiments are 
designed and are being conducted in our laboratory. 
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APPENDIX A: SEQUENCE ALIGNMENTS  
Sequence alingments of fetal human cDNA library are given below: 
 
 
1. Meteorin, glial cell differentiation regulator 
 
 Score = 1360 bits (736),  Expect = 0.0 Identities = 761/773 (98%), Gaps = 1/773 (0%) 
 Strand=Plus/Plus 
 
Query  123   CCAAACACTTCTGCAAACACTAGAAAAGGAGGTAGCCCGTGTGCCCTCCTGCACCGCCTC  182 
             ||||||||||||||||| |||||||||||||||| ||||||||||||||||||||||||| 
Metrn  2713  CCAAACACTTCTGCAAATACTAGAAAAGGAGGTAACCCGTGTGCCCTCCTGCACCGCCTC  2772 
 
Query  183   CTCCACTCCTGTCTTGGAGAGGCTTTCCCGTGGGCCGAGCAACCCCCTTACCTTTGGCAC  242 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  2773  CTCCACTCCTGTCTTGGAGAGGCTTTCCCGTGGGCCGAGCAACCCCCTTACCTTTGGCAC  2832 
 
Query  243   TTGCCCTGATTCTCTGGCCAGCTTCCTACAACCTCTCCTTTTCAGCCACACCCAAGTCCA  302 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  2833  TTGCCCTGATTCTCTGGCCAGCTTCCTACAACCTCTCCTTTTCAGCCACACCCAAGTCCA  2892 
 
Query  303   CCTGTTCACAAACACCCTGGGCTGGGCCCTGGCCGAACCCTGGCTTCTACCTACCTGTCT  362 
             ||||||||||||||||||||||||||||||||| ||||||||||||||||| |||||||| 
Metrn  2893  CCTGTTCACAAACACCCTGGGCTGGGCCCTGGCAGAACCCTGGCTTCTACCCACCTGTCT  2952 
 
Query  363   CAGGAAGTGCCTGAGCCTTGCACCTACAGACCCTCCCAGAGAAAGCCCTGGCTTTGCAAC  422 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  2953  CAGGAAGTGCCTGAGCCTTGCACCTACAGACCCTCCCAGAGAAAGCCCTGGCTTTGCAAC  3012 
 
Query  423   CAGCTGTCTTCTCATGAGACACAGGGCCACAGGAGCACCACGGTGCCCAAATGGGTCTTG  482 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  3013  CAGCTGTCTTCTCATGAGACACAGGGCCACAGGAGCACCACGGTGCCCAAATGGGTCTTG  3072 
 
Query  483   GAGCATTAGACCAGGGGCTTCATGCCTGCCCTGGGGACAGGTGGCCAAAGTGGCATGGGA  542 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  3073  GAGCATTAGACCAGGGGCTTCATGCCTGCCCTGGGGACAGGTGGCCAAAGTGGCATGGGA  3132 
 
Query  543   GATAGGGAGACAGTGTGGGTGAGCAGGTGGGCAGGAGCTACAGGAGCCTGGGGCCTGTGG  602 
             ||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  3133  GATAGGGAGACGGTGTGGGTGAGCAGGTGGGCAGGAGCTACAGGAGCCTGGGGCCTGTGG  3192 
 
Query  603   ATCACAGACACCGCCAGGCAAGTGCCAGTTCACACAGGTACAGGTGGCTGCAGAGTGCCC  662 
             ||||||||||||| |||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  3193  ATCACAGACACCGTCAGGCAAGTGCCAGTTCACACAGGTACAGGTGGCTGCAGAGTGCCC  3252 
 
Query  663   AAAGGCCAAGCAGCAGAGTGCCTGGTGTGGACGGGAGAGGAGTGGGGAGGTTGGGCGCAG  722 
             |||||||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Metrn  3253  AAAGGCCAAGAAGCAGAGTGCCTGGTGTGGACGGGAGAGGAGTGGGGAGGTTGGGCGCAG  3312 
 
Query  723   TGGCTCACGCCTGTAATCCCAACACTTTGGGAGGCCCAGGCAAGCAGATCATGAGGTCAG  782 
             ||||||| |||||||||||||||||||||||||||| ||||||||||||||||||||||| 
Metrn  3313  TGGCTCATGCCTGTAATCCCAACACTTTGGGAGGCCGAGGCAAGCAGATCATGAGGTCAG  3372 
 
Query  783   GAGATGGAGACCATCCTGGCCAACATGGTGAAACCGTCTCTAATATAACACAAAAAATTA  842 
             ||||||||||||||||||||||||||||||||||||||||||||| |||||||||||||| 
Metrn  3373  GAGATGGAGACCATCCTGGCCAACATGGTGAAACCGTCTCTAATAAAACACAAAAAATTA  3432 
 
Query  843   GCCAGACCTTGGTGGCATGCATCTGTAATCCCAGCTACTCAAAAGGCTGAGGC  895 
             ||||||| | ||||||||||||||||||||||||||||||||||||||||||| 
Metrn  3433  GCCAGACGT-GGTGGCATGCATCTGTAATCCCAGCTACTCAAAAGGCTGAGGC  3484 
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2. SH3-domain GRB2-like endophilin B2 [Homo sapiens] 
 
 Score = 1511 bits (818),  Expect = 0.0 Identities = 868/888 (97%), Gaps = 19/888 
(2%) 
 Strand=Plus/Plus 
 
Query  122   CCTCCGCGCTCTGGAATGATGAAGTGGACAAGGCCGAGCAGGAGCTCCGCGTGGCCCAGA  181 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    763   CCTCCGCGCTCTGGAATGATGAAGTGGACAAGGCCGAGCAGGAGCTCCGCGTGGCCCAGA  822 
 
Query  182   CAGAGTTTGACCGGCAAGCAGAAGTGACCCGTCTCTTGCTGGAGGGAATCAGTAGCACTC  241 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    823   CAGAGTTTGACCGGCAAGCAGAAGTGACCCGTCTCTTGCTGGAGGGAATCAGTAGCACTC  882 
 
Query  242   ACGTGAACCACCTGCGCTGCCTCCACGAGTTCGTCAAGTCTCAGACAACCTACTACGCAC  301 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    883   ACGTGAACCACCTGCGCTGCCTCCACGAGTTCGTCAAGTCTCAGACAACCTACTACGCAC  942 
 
Query  302   AGTGCTACCGCCACATGCTGGACTTGCAGAAGCAGCTGGGCAGCTCCCAGGGTGCCATAT  361 
             ||||||||||||||||||||||||||||||||||||| ||  |    ||    |    || 
Sh3    943   AGTGCTACCGCCACATGCTGGACTTGCAGAAGCAGCT-GG--G----CA----G----AT  987 
 
Query  362   TTCCCGGCACCTTCGTGGGCACCACAGAGCCCGCCTCCCCACCCCTGAGCAGCACCTCAC  421 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    988   TTCCCGGCACCTTCGTGGGCACCACAGAGCCCGCCTCCCCACCCCTGAGCAGCACCTCAC  1047 
 
Query  422   CCACCACTGCTGCGGCCACTATGCCTGTGGTGCCCTCTGTGGCCAGCCTGGCCCCTCCGG  481 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
Sh3    1048  CCACCACTGCTGCGGCCACTATGCCTGTGGTGCCCTCTGTGGCCAGCCTGGCCCCTCCAG  1107 
 
Query  482   GGGAGGCCTCGCTCTGCCTGGAAGAGGTGGcccccccTGCCAGTGGGACCCGCAAAGCTC  541 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1108  GGGAGGCCTCGCTCTGCCTGGAAGAGGTGGCCCCCCCTGCCAGTGGGACCCGCAAAGCTC  1167 
 
Query  542   GGGTGCTCTATGACTACGAGGCAGCCGACAGCAGTGAGCTGGCCCTGCTGGCTGATGAGC  601 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1168  GGGTGCTCTATGACTACGAGGCAGCCGACAGCAGTGAGCTGGCCCTGCTGGCTGATGAGC  1227 
 
Query  602   TCATCACTGTCTACAGCCTGCCTGGCATGGACCCTGACTGGCTCATTGGCGAGAGAGGCA  661 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1228  TCATCACTGTCTACAGCCTGCCTGGCATGGACCCTGACTGGCTCATTGGCGAGAGAGGCA  1287 
 
Query  662   ACAAGAAGGGCAAGGTCCCTGTCACCTACTTGGAACTGCTCAGCTAGGCAGGTGccccca  721 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1288  ACAAGAAGGGCAAGGTCCCTGTCACCTACTTGGAACTGCTCAGCTAGGCAGGTGCCCCCA  1347 
 
Query  722   tcccccccGCATTCTGGCCTAGGCAGGAGAGGATGGGCGCAGCCCTGCCACTTAACTTGT  781 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1348  TCCCCCCCGCATTCTGGCCTAGGCAGGAGAGGATGGGCGCAGCCCTGCCACTTAACTTGT  1407 
 
Query  782   TTGTTGGTGACACAGTTGTTCA-AGGTGGGGGGAGAATTCACCCCATTCTGTCCCTGCCC  840 
             |||||||||||||||||||||| || |||||  ||||||||||||||||||||||||||| 
Sh3    1408  TTGTTGGTGACACAGTTGTTCAGAG-TGGGG--AGAATTCACCCCATTCTGTCCCTGCCC  1464 
 
Query  841   CTAGTCACCTAGCTGTGAGGGTGCCTGAGGCTGAATGGCTCCAcccctcccccagccctg  900 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1465  CTAGTCACCTAGCTGTGAGGGTGCCTGAGGCTGAATGGCTCCACCCCTCCCCCAGCCCTG  1524 
 
Query  901   cttctgacctgtggctctggagcccctgcccctgcctgcatccccGAGCACCCCACCCTC  960 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1525  CTTCTGACCTGTGGCTCTGGAGCCCCTGCCCCTGCCTGCATCCCCGAGCACCCCACCCTC  1584 
 
Query  961   CAGGCTCCACTAAGGAGGGAGGGGCTGTCTGCAGCAGCTGCACTCAGC  1008 
             |||||||||||||||||||||||||||||||||||||||||||||||| 
Sh3    1585  CAGGCTCCACTAAGGAGGGAGGGGCTGTCTGCAGCAGCTGCACTCAGC  1632 
 
3. zinc finger family member 767 [Homo sapiens] 
 
 Score =  959 bits (519),  Expect = 0.0, Identities = 541/552 (98%), Gaps = 0/552 
(0%), 
 Strand=Plus/Plus 
 
Query  135   CTGAAAAGACGCACAAAGAATGGCCATAAAAGATATGAGCAACCCCAGCTTTCCAGACAG  194 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Zincf  1183  CTGAAAAGACGCACAAAGAATGGCCATAAAAGATATGAGCAACCCCAGCTTTCCAGACAG  1242 
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Query  195   TCACTTTTCCCAGTGGTCATACCTGGTCTGGAAGATTCCCCATCATCTCGAATAAAGCTG  254 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Zincf  1243  TCACTTTTCCCAGTGGTCATACCTGGTCTGGAAGATTCCCCATCATCTCGAATAAAGCTG  1302 
 
Query  255   TTGTTGCTTTTAACTCCATGGAGAGACCGAATGGAGTGAGCCCAGCAGGGCATGCTGGGC  314 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Zincf  1303  TTGTTGCTTTTAACTCCATGGAGAGACCGAATGGAGTGAGCCCAGCAGGGCATGCTGGGC  1362 
 
 
Query  315   AAGAGAGGTCCCCCGAGTCCCAAATAAGAATTTCAACTAGTATAAAACGAGGCAGCGAAC  374 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Zincf  1363  AAGAGAGGTCCCCCGAGTCCCAAATAAGAATTTCAACTAGTATAAAACGAGGCAGCGAAC  1422 
 
Query  375   CCACACGTGGAAGTCTGATACCGCTTGCAGAAGGGAATTGAATAGATGTCTCCCTATTGG  434 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Zincf  1423  CCACACGTGGAAGTCTGATACCGCTTGCAGAAGGGAATTGAATAGATGTCTCCCTATTGG  1482 
 
Query  435   TAAGGATGTGGTTTTCTTGACTTGAAATTACAAAGCCCGCAAGCAACATCTGATCATCCG  494 
             ||||||||||||||| |||||||||||| ||||||||||||||||||| ||||||||||| 
Zincf  1483  TAAGGATGTGGTTTTATTGACTTGAAATAACAAAGCCCGCAAGCAACAACTGATCATCCG  1542 
 
Query  495   CGGGATGCTGCCACAAGGAATAATTGAGCACTCATTCAGACACAGGGGAAACCACTGCCT  554 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Zincf  1543  CGGGATGCTGCCACAAGGAATAATTGAGCACTCATTCAGACACAGGGGAAACCACTGCCT  1602 
 
Query  555   CTTTTAGTCTTTCTCCCAGATTCCAACAGTCATTGTTACAGCATTTCACCTTGTTCACCT  614 
             |||| ||||||||||||||||||||||||||| ||||||||||||||||||||||||||| 
Zincf  1603  CTTTCAGTCTTTCTCCCAGATTCCAACAGTCAGTGTTACAGCATTTCACCTTGTTCACCT  1662 
 
Query  615   CTCTGAGAAGACGTTGTTGCTCACTCTCCCTAGTGGGCACTGGGAGCCTCTGCTCAGGTG  674 
             | ||||||||||||||  |||||||| ||| ||||||||||||||||||||||||||||| 
Zincf  1663  CCCTGAGAAGACGTTGCAGCTCACTCACCCCAGTGGGCACTGGGAGCCTCTGCTCAGGTG  1722 
 
Query  675   GGAGATAGATGC  686 
             ||||| |||||| 
Zincf  1723  GGAGACAGATGC  1734 
 
4. solute carrier family 44, member 2 [Homo sapiens] 
 
 Score =  459 bits (248),  Expect = 1e-126 
 Identities = 248/248 (100%), Gaps = 0/248 (0%) 
 Strand=Plus/Plus 
 
Query  108   GGGAACTGGCTTCCCAGTTGCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTCATGTC  167 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CTL2   3142  GGGAACTGGCTTCCCAGTTGCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTCATGTC  3201 
 
Query  168   TCTGCTCATCAGCACTGTCCCAGGATCCTGGAGAGGGAGAACCCCTGGCCCCAGGGGAAA  227 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CTL2   3202  TCTGCTCATCAGCACTGTCCCAGGATCCTGGAGAGGGAGAACCCCTGGCCCCAGGGGAAA  3261 
 
Query  228   GAggggggggTCTCCCGTTTCCTGTGCCTGCACCAGCCCTGCCCCCATTGCGTCTGCACA  287 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CTL2   3262  GAGGGGGGGGTCTCCCGTTTCCTGTGCCTGCACCAGCCCTGCCCCCATTGCGTCTGCACA  3321 
 
Query  288   CCCCTGCGTGTAACTGCATTCCAACCACTAATAAAGTGCCTATTGTACAGGTAAAAAAAA  347 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CTL2   3322  CCCCTGCGTGTAACTGCATTCCAACCACTAATAAAGTGCCTATTGTACAGGTAAAAAAAA  3381 
 
Query  348   AAAAAAAA  355 
             |||||||| 
CTL2   3382  AAAAAAAA  3389 
 
 
5. KIAA1853 [Homo sapiens] 
 
 Score =  675 bits (365),  Expect = 0.0 
 Identities = 369/371 (99%), Gaps = 0/371 (0%) 
 Strand=Plus/Plus 
 
Query  123   CTTTTGCAAAAGGGTCTGCTTGGAGAGGCCAAAATTCAGGGTGCTCTCAAAGGCAAAGAA  182 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
KIAA1  6382  CTTTTGCAAAAGGGTCTGCTTGGAGAGGCCAAAATTCAGGGTGCTCTCAAAGGCAAAGAA  6441 
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Query  183   AGCACATTGttttccttctccagtccaactttcatcttttcttctgctgttttcttttcc  242 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
KIAA1  6442  AGCACATTGTTTTCCTTCTCCAGTCCAACTTTCATCTTTTCTTCTGCTGTTTTCTTTTCC  6501 
 
 
Query  243   cctcttctttttcACAAATGTTCAAAATGGTCTCATGCGCATGTGTCTTGCCCCACTTTC  302 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
KIAA1  6502  CCTCTTCTTTTTCACAAATGTTCAAAATGGTCTCATGCGCATGTGTCTTGCCCCACTTTC  6561 
 
Query  303   CCCTTTAGCTGAACAGAAAATTTTGTCTCAGTAAAACGAAGTCAAAAAACAGGATTCCTC  362 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
KIAA1  6562  CCCTTTAGCTGAACAGAAAATTTTGTCTCAGTAAAACGAAGTCAAAAAACAGGATTCCTC  6621 
 
Query  363   CAAACATGCCTCCTCCCGCACTGGCCAGCCGATTCCATCTGAGAAACTTATGCTAGATTC  422 
             |||||||||||||||||||||||||||||||| |||| |||||||||||||||||||||| 
KIAA1  6622  CAAACATGCCTCCTCCCGCACTGGCCAGCCGAGTCCAGCTGAGAAACTTATGCTAGATTC  6681 
 
Query  423   AATGTCATTGAGCAATGCTTTATTGAAGTCTCGTTCTTCTCACTTCTGCACCAGTGAGCC  482 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
KIAA1  6682  AATGTCATTGAGCAATGCTTTATTGAAGTCTCGTTCTTCTCACTTCTGCACCAGTGAGCC  6741 
 
Query  483   AATGATACTGA  493 
             ||||||||||| 
KIAA1  6742  AATGATACTGA  6752 
 
 
6. WAS protein family, member 2 [Homo sapiens] 
 
 Score = 1530 bits (828),  Expect = 0.0 
 Identities = 847/855 (99%), Gaps = 5/855 (0%) 
 Strand=Plus/Plus 
 
Query  124   CCTCTCTGGGGGACCAGAAGTAGTGAGAGAAGGAAGGGGATAGGCAGCTTTGACAGGTGC  183 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    2905  CCTCTCTGGGGGACCAGAAGTAGTGAGAGAAGGAAGGGGATAGGCAGCTTTGACAGGTGC  2964 
 
Query  184   TGCTTTCAATTCCTCTGCAACTCCTCCCCCTTTTATTTCCCCAATTTAAACAAAGATTCT  243 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    2965  TGCTTTCAATTCCTCTGCAACTCCTCCCCCTTTTATTTCCCCAATTTAAACAAAGATTCT  3024 
 
Query  244   GCCAACTGTGGAAACTTCAGTCCCTCAGGCTGGCAGCCATGCCAGTACCTGCCTgggggt  303 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3025  GCCAACTGTGGAAACTTCAGTCCCTCAGGCTGGCAGCCATGCCAGTACCTGCCTGGGGGT  3084 
 
Query  304   ggggggTGCCTGGCAGCCATGAAGCAGGCTGAAAGGCAGAGGGGCTCCAGGTCCTGTTTC  363 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3085  GGGGGGTGCCTGGCAGCCATGAAGCAGGCTGAAAGGCAGAGGGGCTCCAGGTCCTGTTTC  3144 
 
Query  364   CAGCTCCCCTCACTGCACATGGTGAAGCTCGCTCCCTCCCTCCCTCCCTTCCCGCTTTTC  423 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3145  CAGCTCCCCTCACTGCACATGGTGAAGCTCGCTCCCTCCCTCCCTCCCTTCCCGCTTTTC  3204 
 
Query  424   CCAGAGCTAATACACAGGTGCTATTATTCAGaaaaaaaCTGGTCAGCTCTAGCCAACAGT  483 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3205  CCAGAGCTAATACACAGGTGCTATTATTCAGAAAAAAACTGGTCAGCTCTAGCCAACAGT  3264 
 
Query  484   GAGGTTTCTTTTCTTCTGCCCTAACTATTGTGTAGCCTCTTATGCTGAAATCGGCTTCTG  543 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3265  GAGGTTTCTTTTCTTCTGCCCTAACTATTGTGTAGCCTCTTATGCTGAAATCGGCTTCTG  3324 
 
Query  544   CTGGCTTCTCCGGCTTTCAGAGCCCTGAAACAAAGAGAAACAGGATCTGTCCCTACCCAG  603 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3325  CTGGCTTCTCCGGCTTTCAGAGCCCTGAAACAAAGAGAAACAGGATCTGTCCCTACCCAG  3384 
 
Query  604   CACAGCAAATGGTTGTAGTAATTGCCAAAGCCCTCATAAAGCCCTCCGGCTTGAGGAGAG  663 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3385  CACAGCAAATGGTTGTAGTAATTGCCAAAGCCCTCATAAAGCCCTCCGGCTTGAGGAGAG  3444 
 
Query  664   AGTGTATAGTCATGGGTTCTGCCTCTGTGCCCTTGCTGGCCGCTTCTCCTCTGCCTTCTT  723 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3445  AGTGTATAGTCATGGGTTCTGCCTCTGTGCCCTTGCTGGCCGCTTCTCCTCTGCCTTCTT  3504 
 
Query  724   TCCTGGAACTCAGGGTGTGGGGACTGAGCCTGTAGGGGACAGCATGCCGTCTTGCTGTGG  783 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
WAS    3505  TCCTGGAACTCAGGGTGTGGGGACTGAGCCTGTAGGGGACAGCATGCCGTCTTGCTGTGG  3564 
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Query  784   CCACTCCCAAGTGTGCCCTCTTCCCTCTTTACACATCATGTGTCTCTGGCACAGGACTTG  843 
             |||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||| 
WAS    3565  CCACTCCCAAGTGTGCCCTCTTCCCTCTTTACACATCAGGTGTCTCTGGCACAGGACTTG  3624 
 
Query  844   GCACTAAGCTCCCATGCTGAGACACCAGGCTATGTGGGGCCCCCACCTTGTTTCCCAGCC  903 
             |||||||||||| ||||||||||||||||||||||||| ||||||||||||||||||||| 
WAS    3625  GCACTAAGCTCC-ATGCTGAGACACCAGGCTATGTGGG-CCCCCACCTTGTTTCCCAGCC  3682 
 
Query  904   TGCACCTTAAAAGCCGAAAGGTGCTTTCATCAGAACCCTAAAAAGGTCGTTGAAGGCGC-  962 
             ||||||||| |||||||| |||||||||||||||||||||||| |||||||||||||||  
WAS    3683  TGCACCTTAGAAGCCGAA-GGTGCTTTCATCAGAACCCTAAAATGGTCGTTGAAGGCGCC  3741 
 
Query  963   TGGGGCCGCAGCCCA  977 
             |||| |||||||||| 
WAS    3742  TGGG-CCGCAGCCCA  3755 
 
 
 
7. Homo sapiens actin, beta (ACTB), mRNA 
 
 Score = 1016 bits (550),  Expect = 0.0 
 Identities = 550/550 (100%), Gaps = 0/550 (0%) 
 Strand=Plus/Plus 
 
Query  124   GCCACGGCTGCTTCCAGCTCCTCCCTGGAGAAGAGCTACGAGCTGCCTGACGGCCAGGTC  183 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   766   GCCACGGCTGCTTCCAGCTCCTCCCTGGAGAAGAGCTACGAGCTGCCTGACGGCCAGGTC  825 
 
Query  184   ATCACCATTGGCAATGAGCGGTTCCGCTGCCCTGAGGCACTCTTCCAGCCTTCCTTCCTG  243 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   826   ATCACCATTGGCAATGAGCGGTTCCGCTGCCCTGAGGCACTCTTCCAGCCTTCCTTCCTG  885 
 
Query  244   GGCATGGAGTCCTGTGGCATCCACGAAACTACCTTCAACTCCATCATGAAGTGTGACGTG  303 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   886   GGCATGGAGTCCTGTGGCATCCACGAAACTACCTTCAACTCCATCATGAAGTGTGACGTG  945 
 
Query  304   GACATCCGCAAAGACCTGTACGCCAACACAGTGCTGTCTGGCGGCACCACCATGTACCCT  363 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   946   GACATCCGCAAAGACCTGTACGCCAACACAGTGCTGTCTGGCGGCACCACCATGTACCCT  1005 
 
Query  364   GGCATTGCCGACAGGATGCAGAAGGAGATCACTGCCCTGGCACCCAGCACAATGAAGATC  423 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   1006  GGCATTGCCGACAGGATGCAGAAGGAGATCACTGCCCTGGCACCCAGCACAATGAAGATC  1065 
 
Query  424   AAGATCATTGCTCCTCCTGAGCGCAAGTACTCCGTGTGGATCGGCGGCTCCATCCTGGCC  483 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   1066  AAGATCATTGCTCCTCCTGAGCGCAAGTACTCCGTGTGGATCGGCGGCTCCATCCTGGCC  1125 
 
Query  484   TCGCTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGACGAGTCCGGCCCC  543 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   1126  TCGCTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGACGAGTCCGGCCCC  1185 
 
Query  544   TCCATCGTCCACCGCAAATGCTTCTAGGCGGACTATGACTTAGTTGCGTTACACCCTTTC  603 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   1186  TCCATCGTCCACCGCAAATGCTTCTAGGCGGACTATGACTTAGTTGCGTTACACCCTTTC  1245 
 
Query  604   TTGACAAAACCTAACTTGCGCAGAAAACAAGATGAGATTGGCATGGCTTTATTTGttttt  663 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ACTB   1246  TTGACAAAACCTAACTTGCGCAGAAAACAAGATGAGATTGGCATGGCTTTATTTGTTTTT  1305 
 
Query  664   tttGTTTTGT  673 
             |||||||||| 
ACTB   1306  TTTGTTTTGT  1315 
 
8. chromosome 9 open reading frame 127 [Homo sapiens] 
 
 
 Score = 1674 bits (906),  Expect = 0.0 
 Identities = 906/906 (100%), Gaps = 0/906 (0%) 
 Strand=Plus/Plus 
 
Query  120   ACCACCAGGGTTGCCAGGCTGCGAATCCCATTCCCGCAGACGGGGACCTGGTTCCTGGCC  179 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 1697  ACCACCAGGGTTGCCAGGCTGCGAATCCCATTCCCGCAGACGGGGACCTGGTTCCTGGCC  1756 
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Query  180   CTCCGCTCCCTGTGCGGGGTGGGGCCTCGGTTCGTGCGGTGCCGCAACGCGACGGCCGAG  239 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 1757  CTCCGCTCCCTGTGCGGGGTGGGGCCTCGGTTCGTGCGGTGCCGCAACGCGACGGCCGAG  1816 
 
Query  240   GTGCGGATGCGCACCTTCCTGTCCCCATGCGTGGACGACTGCGGGCCCTACGGCCAGTGC  299 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 1817  GTGCGGATGCGCACCTTCCTGTCCCCATGCGTGGACGACTGCGGGCCCTACGGCCAGTGC  1876 
 
Query  300   AAGCTGCTGCGCACACACAATTATCTGTACGCAGCCTGCGAGTGCAAGGCCGGGTGGAGA  359 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 1877  AAGCTGCTGCGCACACACAATTATCTGTACGCAGCCTGCGAGTGCAAGGCCGGGTGGAGA  1936 
 
Query  360   GGCTGGGGCTGCACCGACAGTGCAGATGCGCTCACCTATGGATTCCAGCTGCTGTCCACA  419 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 1937  GGCTGGGGCTGCACCGACAGTGCAGATGCGCTCACCTATGGATTCCAGCTGCTGTCCACA  1996 
 
Query  420   CTCCTGCTCTGCCTGAGCAACCTCATGTTTCTGCCACCTGTGGTCCTGGCCATTCGGAGT  479 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 1997  CTCCTGCTCTGCCTGAGCAACCTCATGTTTCTGCCACCTGTGGTCCTGGCCATTCGGAGT  2056 
 
Query  480   CGATATGTGCTGGAAGCTGCAGTCTACACCTTCACCATGTTCTTCTCCACGTTCTATCAT  539 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2057  CGATATGTGCTGGAAGCTGCAGTCTACACCTTCACCATGTTCTTCTCCACGTTCTATCAT  2116 
 
Query  540   GCCTGTGACCAGCCAGGCATCGTGGTTTTCTGCATCATGGACTACGATGTGCTGCAGTTC  599 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2117  GCCTGTGACCAGCCAGGCATCGTGGTTTTCTGCATCATGGACTACGATGTGCTGCAGTTC  2176 
 
Query  600   TGTGATTTCCTGGGCTCCTTAATGTCCGTGTGGGTCACTGTCATTGCCATGGCTCGTTTA  659 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2177  TGTGATTTCCTGGGCTCCTTAATGTCCGTGTGGGTCACTGTCATTGCCATGGCTCGTTTA  2236 
 
Query  660   CAGCCCGTGGTCAAGCAGGTGCTGTATTTGCTGGGAGCTATGCTGCTGTCCATGGCTCTG  719 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2237  CAGCCCGTGGTCAAGCAGGTGCTGTATTTGCTGGGAGCTATGCTGCTGTCCATGGCTCTG  2296 
 
Query  720   CAGCTTGACCGACATGGACTCTGGAACCTGCTTGGACCCAGTCTCTTCGCCCTGGGGATC  779 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2297  CAGCTTGACCGACATGGACTCTGGAACCTGCTTGGACCCAGTCTCTTCGCCCTGGGGATC  2356 
 
Query  780   TTGGCCACAGCCTGGACAGTACGCAGCGTCCGCCGCCGGCACTGCTACCCACCCACGTGG  839 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2357  TTGGCCACAGCCTGGACAGTACGCAGCGTCCGCCGCCGGCACTGCTACCCACCCACGTGG  2416 
 
Query  840   CGCCGCTGGCTTTTCTACTTGTGCCCTGGCAGCCTTATTGCAGGCAGTGCCGTCCTGCTT  899 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2417  CGCCGCTGGCTTTTCTACTTGTGCCCTGGCAGCCTTATTGCAGGCAGTGCCGTCCTGCTT  2476 
 
Query  900   TATGCTTTTGTGGAGACCCGGGACAACTACTTCTACATTCACAGCATTTGGCATATGCTC  959 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2477  TATGCTTTTGTGGAGACCCGGGACAACTACTTCTACATTCACAGCATTTGGCATATGCTC  2536 
 
Query  960   ATTGCGGGCAGTGTGGGCTTCCTGCTGCCCCCTCGTGCCAAGACTGACCACGGGGTCCCA  1019 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ORF127 2537  ATTGCGGGCAGTGTGGGCTTCCTGCTGCCCCCTCGTGCCAAGACTGACCACGGGGTCCCA  2596 
 
Query  1020  TCTGGA  1025 
             |||||| 
ORF127 2597  TCTGGA  2602 
 
9. carbohydrate (N-acetylgalactosamine 4-0)sulfotransferase 8 
[Homo sapiens] 
 
 Score = 1138 bits (616),  Expect = 0.0 
 Identities = 616/616 (100%), Gaps = 0/616 (0%) 
 Strand=Plus/Plus 
 
Query  119   CCTCATCCGCGCGCCGCGGAACCTGACCTTCCCCCGGTTCAAGGACCGGCACTCGCAGGA  178 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  1838  CCTCATCCGCGCGCCGCGGAACCTGACCTTCCCCCGGTTCAAGGACCGGCACTCGCAGGA  1897 
 
Query  179   GGCGCGGACCACAGCGAGGATCGCCCACCAGTACTTCGCCCAACTCTCGGCCCTGCAAAG  238 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  1898  GGCGCGGACCACAGCGAGGATCGCCCACCAGTACTTCGCCCAACTCTCGGCCCTGCAAAG  1957 
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Query  239   GCAGCGCACCTACGACTTCTACTACATGGATTACCTGATGTTCAACTATTCCAAGCCCTT  298 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  1958  GCAGCGCACCTACGACTTCTACTACATGGATTACCTGATGTTCAACTATTCCAAGCCCTT  2017 
 
Query  299   TGCAGATCTGTACTGAGGGGCGCCGCAGCTGGCCGGGGCCGCCCTGCCCCGGTCACTCAC  358 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  2018  TGCAGATCTGTACTGAGGGGCGCCGCAGCTGGCCGGGGCCGCCCTGCCCCGGTCACTCAC  2077 
 
Query  359   CTGTGCTCCCGGGCATCCTCCTGTCCCTGGCTCCTCATCCTGGGAGCAACAGGGCTCTGA  418 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  2078  CTGTGCTCCCGGGCATCCTCCTGTCCCTGGCTCCTCATCCTGGGAGCAACAGGGCTCTGA  2137 
 
Query  419   GGACGTGAGGAGCCATCGCTGTGGGAGGCAGCAGGCCCCGGGTGGGGGGCAGAGGCGCCC  478 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  2138  GGACGTGAGGAGCCATCGCTGTGGGAGGCAGCAGGCCCCGGGTGGGGGGCAGAGGCGCCC  2197 
 
Query  479   AGCCTTGGATGGGGACCCCAGCCCCTGGCCTGTACCTGTTTCCTCATTCCTTGGCTGAGG  538 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  2198  AGCCTTGGATGGGGACCCCAGCCCCTGGCCTGTACCTGTTTCCTCATTCCTTGGCTGAGG  2257 
 
Query  539   GAGAGGCTGAGAACTGGGCAGACACCCCTGGAGCTCAGCCGACAGTTTTGATGAGCAGGG  598 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  2258  GAGAGGCTGAGAACTGGGCAGACACCCCTGGAGCTCAGCCGACAGTTTTGATGAGCAGGG  2317 
 
Query  599   AAGTCTGAGGCCCAGAGGACGGGGGGCCCAGCGGTAAGGGATGTCCCGCACTCCCTTAGC  658 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  2318  AAGTCTGAGGCCCAGAGGACGGGGGGCCCAGCGGTAAGGGATGTCCCGCACTCCCTTAGC  2377 
 
Query  659   CATTGCCTTGGACCAAACCACGTGGTTTGCAGCTTTTCTACGAGCCAGGGGGGAGGTTCC  718 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHST8  2378  CATTGCCTTGGACCAAACCACGTGGTTTGCAGCTTTTCTACGAGCCAGGGGGGAGGTTCC  2437 
 
Query  719   CTTGGATTAAGGTTCC  734 
             |||||||||||||||| 
CHST8  2438  CTTGGATTAAGGTTCC  2453 
 
 
10. Calcium binding protein P22 pseudogene[Homo sapiens] 
 
 Score =  346 bits (187),  Expect = 9e-93 
 Identities = 232/254 (91%), Gaps = 2/254 (0%) 
 Strand=Plus/Minus 
 
Query  1     TGGAGGGTAGGGGCACGATCTTGGCTCACTGCAAGCTCCACCTCCCAGGTTCACACCATT  60 
             ||||| |||| |||||||||||||||||||||||||||  |||||||||||||| ||||| 
CHP   1748  TGGAGTGTAGTGGCACGATCTTGGCTCACTGCAAGCTCTGCCTCCCAGGTTCACGCCATT  1689 
 
Query  61    CTCCTGCCTCAGCCTCCC-ATGTAGCTGGGACTACAGGCACCTGCCACCACGCCCGGCTA  119 
             |||||||||||||||||| | ||||||||||||||||||||| ||||||||||||||||| 
CHP   1688  CTCCTGCCTCAGCCTCCCGA-GTAGCTGGGACTACAGGCACCCGCCACCACGCCCGGCTA  1630 
 
 
Query  120   ATTTTTTGTGTATTTAGCAGAGATGGGGTTTCACCGCGTTAGCCAGGATGGTCTCGATCT  179 
             ||||||||| | ||||| | ||| |||||||||||| ||||||||||||||||||||||| 
CHP   1629  ATTTTTTGTATTTTTAGTAAAGACGGGGTTTCACCGTGTTAGCCAGGATGGTCTCGATCT  1570 
 
Query  180   CCTGACCTCGTGATCCGCCCACTTCGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGTC  239 
             ||||||||||||||| |||||| || |||||||| ||||||||||||||||| ||||| | 
CHP   1569  CCTGACCTCGTGATCTGCCCACCTCAGCCTCCCACAGTGCTGGGATTACAGGCGTGAGCC  1510 
 
Query  240   ACCATGCCCGGCTC  253 
             |||| |||| |||| 
CHP   1509  ACCACGCCCAGCTC  1496 
  
11. NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 
22kDa 
 
 Score = 1208 bits (654),  Expect = 0.0 
 Identities = 666/672 (99%), Gaps = 0/672 (0%) 
 Strand=Plus/Plus 
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Query  1    GACCCGGACGGAGGTAGAGGCCAGGGCAGCGCGTCCGGGAGCGGAGTCCGCGCCCGCCGA  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
NADHDH 46   GACCCGGACGGAGGTAGAGGCCAGGGCAGCGCGTCCGGGAGCGGAGTCCGCGCCCGCCGC  105 
 
Query  61   AGCCAGGCCGGACAGCTGGGACAAGGATGTGTACCCTGAGCCCCCGCGCCGCACGCCGGT  120 
             |||| |||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 106  CGCCATGCCGGACAGCTGGGACAAGGATGTGTACCCTGAGCCCCCGCGCCGCACGCCGGT  165 
 
Query  121  GCAGCCCAATCCCATCGTCTACATGATGAAAGCGTTCGACCTCATCGTGGACCGACCCGT  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 166  GCAGCCCAATCCCATCGTCTACATGATGAAAGCGTTCGACCTCATCGTGGACCGACCCGT  225 
 
Query  181  GACCCTCGTGAGAGAATTTATAGAGCGGCAGCACGCAAAGAACAGGTATTACTACTACCA  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 226  GACCCTCGTGAGAGAATTTATAGAGCGGCAGCACGCAAAGAACAGGTATTACTACTACCA  285 
 
Query  241  CCGGCAGTACCGCCGCGTGCCAGACATCACTGAGTGCAAGGAGGAGGACATCATGTGCAT  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 286  CCGGCAGTACCGCCGCGTGCCAGACATCACTGAGTGCAAGGAGGAGGACATCATGTGCAT  345 
 
Query  301  GTATGAAGCCGAAATGCAGTGGAAGAGGGACTACAAAGTCGACCAAGAAATTATCAACAT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 346  GTATGAAGCCGAAATGCAGTGGAAGAGGGACTACAAAGTCGACCAAGAAATTATCAACAT  405 
 
Query  361  TATGCAGGATCGGCTCAAAGCCTGTCAGCAGAGGGAAGGACAGAACTACCAGCAGAACTG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 406  TATGCAGGATCGGCTCAAAGCCTGTCAGCAGAGGGAAGGACAGAACTACCAGCAGAACTG  465 
 
Query  421  TATCAAGGAAGTGGAGCAGTTCACCCAGGTGGCCAAGGCCTACCAGGACCGCTATCAGGA  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 466  TATCAAGGAAGTGGAGCAGTTCACCCAGGTGGCCAAGGCCTACCAGGACCGCTATCAGGA  525 
 
Query  481  CCTGGGGGCCTACAGTTCTGCCAGGAAGTGCCTGGCCAAACAGAGGCAGAGGATGCTGCA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 526  CCTGGGGGCCTACAGTTCTGCCAGGAAGTGCCTGGCCAAACAGAGGCAGAGGATGCTGCA  585 
 
Query  541  AGAGAGAAAAGCTGCAAAAGAGGCCGCCGCTGCCACCTCCTGAGGCAGCTGTGGGTGCCC  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
NADHDH 586  AGAGAGAAAAGCTGCAAAAGAGGCCGCCGCTGCCACCTCCTGAGGCAGCTGTGGGTGCCC  645 
 
Query  601  CTGCTGTGTGGCTCTGTATGACTGTTGCTGAAATATAAAGTCCTGCATTCTGaaaaaaaa  660 
            |||||||||||||||||||||||||||||||||||||||| ||||||  ||||||||||| 
NADHDH 646  CTGCTGTGTGGCTCTGTATGACTGTTGCTGAAATATAAAGCCCTGCAACCTGAAAAAAAA  705 
 
Query  661  aaaaaaaaaaaa  672 
            |||||||||||| 
NADHDH 706  AAAAAAAAAAAA  717 
 
 
 
12. Rho-guanine nucleotide exchange factor [Homo sapiens] 
 
 Score =  985 bits (533),  Expect = 0.0 
 Identities = 600/632 (94%), Gaps = 6/632 (0%) 
 Strand=Plus/Plus 
 
Query  78    CATGCACCAAGAAATTCCAAGAGAAATATAACAAGAACAAACCACAGACCATCCTTGGaa  137 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
RhoGEF 2269  CATGCACCAAGAAATTCCAAGAGAAATATAACAAGAACAAACCACAGACCATCCTTGG-A  2327 
 
Query  138   aaaaaaaGA-GAAGGAGACATCCCACTTTCCTGGTCTCTCCTTGCACCCTTCTTCCTCCG  196 
             ||      |   | ||||||||||||   ||||||||||||||||||||||||||||||| 
RhoGEF 2328  AATTCTTCATTTA-GAGACATCCCAC-AGCCTGGTCTCTCCTTGCACCCTTCTTCCTCCG  2385 
 
Query  197   TGCCTGTTGGATTGCCGACTGGAAGGAGGGATACTGTGGGACAGGTCCATCCATTGTCCA  256 
             ||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| 
RhoGEF 2386  TGCCTGTTGGATTGCCGACTGGAAGGAGGGAGACTGTGGGACAGGTCCATCCATTGTCCA  2445 
 
Query  257   GAAGTGTTCCAGGTACCACCTTGGAATGTTTCAGGAGGTCAGCCACATCCTTGGAGTCTG  316 
             ||||||||||||| |||||||||||| | ||||||||||||||||||||||||||||||| 
RhoGEF 2446  GAAGTGTTCCAGGCACCACCTTGGAAAGCTTCAGGAGGTCAGCCACATCCTTGGAGTCTG  2505 
 
Query  317   AGAGTGACAATAACAGCTGCAGAAGCAGGTCTCATTCttttttatttttttACAGTCCAT  376 
             |||||||| |||||||||||||||||||||||||||| |  | |   |  |||||||||| 
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RhoGEF 2506  AGAGTGACCATAACAGCTGCAGAAGCAGGTCTCATTC-TGATGA-GCTGCTACAGTCCAT  2563 
 
Query  377   GGGCTCTTCTCCCTCTTTTGAGTCTTTCATAATGGAAGATGTTGTGGATTCTTCTCTGTG  436 
             ||||||||||||||||   ||||||||||||||||||||||||||||||||||||||||| 
RhoGEF 2564  GGGCTCTTCTCCCTCTACAGAGTCTTTCATAATGGAAGATGTTGTGGATTCTTCTCTGTG  2623 
 
Query  437   GAGTGACCTCAGCAGTGATGCCCAGGAGTTTGAAGCAGAATCTTGGAGTCTTGTGGTGGA  496 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGEF 2624  GAGTGACCTCAGCAGTGATGCCCAGGAGTTTGAAGCAGAATCTTGGAGTCTTGTGGTGGA  2683 
 
Query  497   TCCCTCATTTTGTAATAGGCAGGAGAAGGATGTCATCAAAAGACAGGATGTCATTTTTGA  556 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGEF 2684  TCCCTCATTTTGTAATAGGCAGGAGAAGGATGTCATCAAAAGACAGGATGTCATTTTTGA  2743 
 
Query  557   GCTAATGCAAACAGAGATGCATCACATCCAGACCCTGTTCATCATGTCTGAGATCTTCAG  616 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGEF 2744  GCTAATGCAAACAGAGATGCATCACATCCAGACCCTGTTCATCATGTCTGAGATCTTCAG  2803 
 
Query  617   GAAAGGCATGAAAGAGGAGCTGCAGCTGGACCACAGCACCGTGGATAAAATTTTCCCCTG  676 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGEF 2804  GAAAGGCATGAAAGAGGAGCTGCAGCTGGACCACAGCACCGTGGATAAAATTTTCCCCTG  2863 
 
Query  677   TTTAAATGAGTTGCTTGAAATCCACAGGCATT  708 
             |||| ||||||||||||||||||||||||||| 
RhoGEF 2864  TTTAGATGAGTTGCTTGAAATCCACAGGCATT  2895 
 
13. glucose-6-phosphate dehydrogenase [Homo sapiens] 
 
 Score =  424 bits (229),  Expect = 2e-115 
 Identities = 324/370 (87%), Gaps = 6/370 (1%) 
 Strand=Plus/Plus 
 
Query  33    GCGAGCAGCCCAACTAGGCCGTGTACACCAAGATGATGACCAAGAAGCCGGGCATGTTCT  92 
             ||| |||||||||| ||||||||||||||||||||||||||||||||||||||||||||| 
G6PDH  1242  GCGTGCAGCCCAACGAGGCCGTGTACACCAAGATGATGACCAAGAAGCCGGGCATGTTCT  1301 
 
Query  93    aaaaaaaGGTGAAAG-CGGAGCTGGTTCTGACCTACGGCAACAGATACAAGAACGTGAAG  151 
               ||    | |  || |||||||||  ||||||||||||||||||||||||||||||||| 
G6PDH  1302  TCAACCCCGAG-GAGTCGGAGCTGGACCTGACCTACGGCAACAGATACAAGAACGTGAAG  1360 
 
Query  152   CTCCCTGACGCCTACGAGCGCCTCATCCTTTTCCCTCTTCTGCGGAAGCCAGATGCACTT  211 
             |||||||||||||||||||||||||||||   |  |||||||||| |||||||||||||| 
G6PDH  1361  CTCCCTGACGCCTACGAGCGCCTCATCCTGGACG-TCTTCTGCGGGAGCCAGATGCACTT  1419 
 
Query  212   CGTGCGCAGCGACGAGCTCCGTGAGTTTTTGTCGTATTTTCACCCCACTGCTGCACCAGA  271 
             |||||||||||||||||||||||||   | | |||||||||||||||||||||||||||| 
G6PDH  1420  CGTGCGCAGCGACGAGCTCCGTGAGGCCTGG-CGTATTTTCACCCCACTGCTGCACCAGA  1478 
 
Query  272   TTGAGCTGGAGAAGCCCAAGCCCATCCCCTATATTTATGTTTTTCCTTTTTCCCACGGAG  331 
             |||||||||||||||||||||||||||||||||||||||     ||     ||||||||| 
G6PDH  1479  TTGAGCTGGAGAAGCCCAAGCCCATCCCCTATATTTATGGCAG-CCGAGGCCCCACGGAG  1537 
 
Query  332   GCAGACGAGCTGAtttttttttttGGGTTTCCAGTATTAGGGCTCCTACAAGTGGGTGAA  391 
             ||||||||||||||        | ||||||||||||| ||||| |||||||||||||||| 
G6PDH  1538  GCAGACGAGCTGATGAAGAGAGT-GGGTTTCCAGTATGAGGGCACCTACAAGTGGGTGAA  1596 
 
Query  392   CCCCCACAAG  401 
             |||||||||| 
G6PDH  1597  CCCCCACAAG  1606 
 
 
14. Homo sapiens chondroitin polymerizing factor (CHPF), mRNA 
 
 
 Score = 1452 bits (786),  Expect = 0.0 
 Identities = 806/815 (98%), Gaps = 4/815 (0%) 
 Strand=Plus/Plus 
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Query  38    GGAGCCAGTGCAGGAGGGGGACCCTCATTTCCGAAGTGCCCTGACAGCCCACCCTGTGCG  97 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1151  GGAGCCAGTGCAGGAGGGGGACCCTCATTTCCGAAGTGCCCTGACAGCCCACCCTGTGCG  1210 
 
Query  98    AGA-ACTGTGCACATGTACCAGTTGCACAAAGCTTTCGCCCGAGCTGAACTGGAACGCAC  156 
              ||  ||||||||||||||||| ||||||||||||||||||||||||||||||||||||| 
CHPF   1211  TGACCCTGTGCACATGTACCAGCTGCACAAAGCTTTCGCCCGAGCTGAACTGGAACGCAC  1270 
 
Query  157   GTACCAGGAGATCCAGGAGTTACAGTGGGAGATCCAGAATACCAGCCATCTGGCCGTTGA  216 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1271  GTACCAGGAGATCCAGGAGTTACAGTGGGAGATCCAGAATACCAGCCATCTGGCCGTTGA  1330 
 
Query  217   TGGGGACCGGGCAGCTGCTTGGCCCGTGGGTATTCCAGCACCATCCCGCCCGGCCTCCCG  276 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1331  TGGGGACCGGGCAGCTGCTTGGCCCGTGGGTATTCCAGCACCATCCCGCCCGGCCTCCCG  1390 
 
Query  277   CTTTGAGGTGCTGCGCTGGGACTACTTCACGGAGCAGCATGCTTTCTCCTGCGCCGATGG  336 
             ||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||| 
CHPF   1391  CTTTGAGGTGCTGCGCTGGGACTACTTCACGGAGCAGCACGCTTTCTCCTGCGCCGATGG  1450 
 
Query  337   CTCACCCCGCTGCCCACTGCGTGGGGCTGACCGGGCTGATGTGGCCGATGTTCTGGGGAC  396 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1451  CTCACCCCGCTGCCCACTGCGTGGGGCTGACCGGGCTGATGTGGCCGATGTTCTGGGGAC  1510 
 
Query  397   AGCTCTAGAGGAGCTGAACCGCCGCTACCACCCGGCCTTGCGGCTCCAGAAGCAGCAGCT  456 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1511  AGCTCTAGAGGAGCTGAACCGCCGCTACCACCCGGCCTTGCGGCTCCAGAAGCAGCAGCT  1570 
 
Query  457   GGTGAATGGCTACCGACGCTTTGATCCGGCCCGGGGTATGGAATACACGCTGGACTTGCA  516 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1571  GGTGAATGGCTACCGACGCTTTGATCCGGCCCGGGGTATGGAATACACGCTGGACTTGCA  1630 
 
Query  517   GCTGGAGGCACTGACCCCCCAGGGAGGCCGCCGGCCCCTCACTCGCCGAGTGCAGCTGCT  576 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1631  GCTGGAGGCACTGACCCCCCAGGGAGGCCGCCGGCCCCTCACTCGCCGAGTGCAGCTGCT  1690 
 
Query  577   CCGGCCGCTGAGCCGCGTGGAGATCTTGCCTGTGCCCTATGTCACTGAGGCCTCACGTCT  636 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1691  CCGGCCGCTGAGCCGCGTGGAGATCTTGCCTGTGCCCTATGTCACTGAGGCCTCACGTCT  1750 
 
Query  637   CACTGTGCTGCTGCCTCTAGCTGCGGCTGAGCGTGACCTGGCCCCTGGCTTCTTGGAGGC  696 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1751  CACTGTGCTGCTGCCTCTAGCTGCGGCTGAGCGTGACCTGGCCCCTGGCTTCTTGGAGGC  1810 
 
Query  697   CTTTGCCACTGCAGCACTGGAGCCTGGTGATGCTGCGGCAGCCCTGACCCTGCTGCTACT  756 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CHPF   1811  CTTTGCCACTGCAGCACTGGAGCCTGGTGATGCTGCGGCAGCCCTGACCCTGCTGCTACT  1870 
 
Query  757   GTATGAGCCGCGCCAGGCCCAGCGCGTGGCCCATGCAGATGTCTTC-CACCTGTCAAGGC  815 
             |||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||| 
CHPF   1871  GTATGAGCCGCGCCAGGCCCAGCGCGTGGCCCATGCAGATGTCTTCGCACCTGTCAAGGC  1930 
 
Query  816   CCATTGTGGCAGAGCTGGAGCGGCGTTTTCCCCGG  850 
             |||  ||||||||||||||||||||||| |||||| 
CHPF   1931  CCAC-GTGGCAGAGCTGGAGCGGCGTTT-CCCCGG  1963 
 
15. myeloid leukemia factor 2 [Homo sapiens] 
 
 Score = 1277 bits (691),  Expect = 0.0 
 Identities = 696/698 (99%), Gaps = 1/698 (0%) 
 Strand=Plus/Plus 
 
Query  38    AGACACGGAGGACTGTTCGGGATTCAGACAGTGGACTGGAGCAGATGTCCATTGGGCATC  97 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   540   AGACACGGAGGACTGTTCGGGATTCAGACAGTGGACTGGAGCAGATGTCCATTGGGCATC  599 
 
Query  98    ACATCCGGGACAGGGCTCACATCCTCCAGCGCTCCCGAAACCATCGCACGGGGGACCAGG  157 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   600   ACATCCGGGACAGGGCTCACATCCTCCAGCGCTCCCGAAACCATCGCACGGGGGACCAGG  659 
 
Query  158   AGGAGCGGCAGGACTATATCAACCTGGATGAGAGTGAGGCCGCAGCGTTTGATGACGAGT  217 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   660   AGGAGCGGCAGGACTATATCAACCTGGATGAGAGTGAGGCCGCAGCGTTTGATGACGAGT  719 
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Query  218   GGCGGCGGGAGACCTCCCGATTCCGGCAGCAGCGTCCCCTGGAGTTTCGGCGGCTTGAGT  277 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   720   GGCGGCGGGAGACCTCCCGATTCCGGCAGCAGCGTCCCCTGGAGTTTCGGCGGCTTGAGT  779 
 
Query  278   CCTCAGGGGCTGGGGGACGAAGGGCGGAGGGGCCTCCCCGCCTGGCCATCCAGGGACCTG  337 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   780   CCTCAGGGGCTGGGGGACGAAGGGCGGAGGGGCCTCCCCGCCTGGCCATCCAGGGACCTG  839 
 
Query  338   AGGACTCCCCTTCCCGACAGTCCCGCCGCTATGACTGGTGAGGGCCCCGGGCCCTCAGCC  397 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   840   AGGACTCCCCTTCCCGACAGTCCCGCCGCTATGACTGGTGAGGGCCCCGGGCCCTCAGCC  899 
 
Query  398   TCTCTTGTACAGGCTGAGAGGCTGAGAAATCATCCCCTGAATAACCTTTTCCTCTCGATT  457 
             ||||||||||||||||||||||||||||||||||||||||||||| |||||||||||||| 
MFL2   900   TCTCTTGTACAGGCTGAGAGGCTGAGAAATCATCCCCTGAATAACTTTTTCCTCTCGATT  959 
 
Query  458   CCCATCCCCAATTTAATATTAAATTAACAGGCAAGCCGGCCCCCACCTCTCCCTGGGGGT  517 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   960   CCCATCCCCAATTTAATATTAAATTAACAGGCAAGCCGGCCCCCACCTCTCCCTGGGGGT  1019 
 
Query  518   CTCAGGGAGAACCTTTCACGGCACCCTTTCCCTACCTTTTCCTTCTTTAATCTCCTGGTT  577 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   1020  CTCAGGGAGAACCTTTCACGGCACCCTTTCCCTACCTTTTCCTTCTTTAATCTCCTGGTT  1079 
 
Query  578   TACCATTGATGACTTCGCCTCTGCATCTACTGACTTGATTTTTCATTCTGCCACTCCATC  637 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   1080  TACCATTGATGACTTCGCCTCTGCATCTACTGACTTGATTTTTCATTCTGCCACTCCATC  1139 
 
Query  638   TTCAAACCCCCTCACCTTTCCCATCCTACTCCTGCCATGCATTGAAGGGTCAATGCATTT  697 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MFL2   1140  TTCAAACCCCCTCACCTTTCCCATCCTACTCCTGCCATGCATTGAAGGGTCAATGCATTT  1199 
 
Query  698   TGGGGGTGAGCTCTGGGTTTAGGGGCCCCCTCCATCCC  735 
             ||||| |||||||||||||||||||||||||||||||| 
MFL2   1200  TGGGG-TGAGCTCTGGGTTTAGGGGCCCCCTCCATCCC  1236 
 
16. leukocyte receptor cluster (LRC) member 8[Homo sapiens] 
 
 Score = 1408 bits (762),  Expect = 0.0 
 Identities = 805/824 (97%), Gaps = 10/824 (1%) 
 Strand=Plus/Plus 
 
Query  104   gtttttattttttGCCTCAgagggatgggattggggaggaggggatgggcagcggagggt  163 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  2736  GTTTTTATTTTTTGCCTCAGAGGGATGGGATTGGGGAGGAGGGGATGGGCAGCGGAGGGT  2795 
 
Query  164   tgggggCATGGTCTGCAGGCTCATCTGTGTCCGCCTTTCACTCCACTAATGCTGTCTCAG  223 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  2796  TGGGGGCATGGTCTGCAGGCTCATCTGTGTCCGCCTTTCACTCCACTAATGCTGTCTCAG  2855 
 
Query  224   TGTTTtctctctctctctTTCGAGCTTGCACTCCGGTACCCGACCCGGCGCCCTGGCCCA  283 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  2856  TGTTTTCTCTCTCTCTCTTTCGAGCTTGCACTCCGGTACCCGACCCGGCGCCCTGGCCCA  2915 
 
Query  284   TCCCATGCCGGGGGGCCAGTGGAAAGAAGACAGGCCGTCCAGCCCGTGCCCGCCTGCGGC  343 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  2916  TCCCATGCCGGGGGGCCAGTGGAAAGAAGACAGGCCGTCCAGCCCGTGCCCGCCTGCGGC  2975 
 
Query  344   GGGGGCACCCAGCAAGCCCGCCCACCGCCCGCTGCCTCACCTGCTTCGCCACAGACTCTT  403 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  2976  GGGGGCACCCAGCAAGCCCGCCCACCGCCCGCTGCCTCACCTGCTTCGCCACAGACTCTT  3035 
 
Query  404   GTTCCCAGCCCCTTGGGGCCTCCGTGTTTGGGGTGGGGGAGCTGCTTAGAGACTGTGCCC  463 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  3036  GTTCCCAGCCCCTTGGGGCCTCCGTGTTTGGGGTGGGGGAGCTGCTTAGAGACTGTGCCC  3095 
 
Query  464   GTCCTCGGCCCCCCACCCTGAAGTGCCAGCACCACCAGCACCAGATCCTCCGCCGCCACA  523 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  3096  GTCCTCGGCCCCCCACCCTGAAGTGCCAGCACCACCAGCACCAGATCCTCCGCCGCCACA  3155 
 
Query  524   CCGCACTGAGGACACGCCGGCCGGGCCGCCTCGTCTCAAGTTGTATAAAGTTGTCTCCGT  583 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  3156  CCGCACTGAGGACACGCCGGCCGGGCCGCCTCGTCTCAAGTTGTATAAAGTTGTCTCCGT  3215 
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Query  584   GTCCCCTCCTCCCTCTGCCCCCAGTGTTTCTTCTGAtttttttttCCCCTTTCCCTCCCT  643 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  3216  GTCCCCTCCTCCCTCTGCCCCCAGTGTTTCTTCTGATTTTTTTTTCCCCTTTCCCTCCCT  3275 
 
Query  644   CCCTCTCCGCATTCTTCCCTTGGTTCAGCACAGGTAAAACGGTTCCCCTCCCTCCCTGCC  703 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
LENG8  3276  CCCTCTCCGCATTCTTCCCTTGGTTCAGCACAGGTAAAACGGTTCCCCTCCCTCCCTGCC  3335 
 
Query  704   TTCATGGATCACCAGCTCACGTCATGTTGCCTTCTCTTTTCTTTGTGTGTGT-TT-ATTT  761 
             |||||||||||||||||||||||||||||||||||||||||||||||||||| || |||| 
LENG8  3336  TTCATGGATCACCAGCTCACGTCATGTTGCCTTCTCTTTTCTTTGTGTGTGTGTTTATTT  3395 
 
Query  762   TAAtttttttttcttccctcctctccctttttcttttgggccctccctccctccctcttc  821 
              || || |||||||||| ||||||||||||| ||||| |||||||||||||||||||||| 
LENG8  3396  -AAGTTATTTTTCTTCC-TCCTCTCCCTTTT-CTTTTTGGCCCTCCCTCCCTCCCTCTTC  3452 
 
Query  822   tGCCATGTAACTGGAGGATGTGCTATGA-TTTGCAAACAGTTGGGTTGTCAGGGTGCttt  880 
             |||||||||||||||||||||||||||| ||||||||||| |||  ||||||| |||||| 
LENG8  3453  TGCCATGTAACTGGAGGATGTGCTATGAGTTTGCAAACAGCTGGACTGTCAGGCTGCTTT  3512 
 
Query  881   tttttCCAAAGGT-CCTCCCTCTGCCTCCCCTTCCCCTCC-CTC  922 
             |||| ||| | || ||||| |||||||||||||||||||| ||| 
LENG8  3513  TTTT-CCAGATGTTCCTCC-TCTGCCTCCCCTTCCCCTCCTCTC  3554 
 
17. small nuclear RNA activating complex, polypeptide 4, 
190kDa [Homo sapiens]  
 
 Score = 1489 bits (806),  Expect = 0.0 
 Identities = 815/819 (99%), Gaps = 2/819 (0%) 
 Strand=Plus/Plus 
 
Query  78    CTGTCCCAGGAGGGCGAGGCGGCCACACAGCAGTGGCTGGGGGGCCAGCGGGGGGTGCGT  137 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 216   CTGTCCCAGGAGGGCGAGGCGGCCACACAGCAGTGGCTGGGGGGCCAGCGGGGGGTGCGT  275 
 
Query  138   GTGCCTCTTCTGGGCAGCAGACTGCCCTATCAGCCCCCAGCCCTGTGCAGCCTGCGAGCT  197 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 276   GTGCCTCTTCTGGGCAGCAGACTGCCCTATCAGCCCCCAGCCCTGTGCAGCCTGCGAGCT  335 
 
Query  198   CTGTCCGGTCTCCTACTCCACAAGAAGGCCCTGGAGCACAAGGCCACCTCCCTGGTGGTG  257 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 336   CTGTCCGGTCTCCTACTCCACAAGAAGGCCCTGGAGCACAAGGCCACCTCCCTGGTGGTG  395 
 
Query  258   GGGGGCGAGGCTGAGCGGCCGGCCGGAGCACTGCAAGCCTCACTGGGGCTGGTGCGGGGG  317 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 396   GGGGGCGAGGCTGAGCGGCCGGCCGGAGCACTGCAAGCCTCACTGGGGCTGGTGCGGGGG  455 
 
Query  318   CAGCTCCAGGACAACCCGGCCTACCTCCTGTTGCGGGCGCGGTTCCTGGCAGCCTTCACC  377 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 456   CAGCTCCAGGACAACCCGGCCTACCTCCTGTTGCGGGCGCGGTTCCTGGCAGCCTTCACC  515 
 
Query  378   CTCCCTGCGCTCCTGGCCACCCTGGCCCCCCAAGGCGTCCGCACCACCCTCTCAGTACCT  437 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 516   CTCCCTGCGCTCCTGGCCACCCTGGCCCCCCAAGGCGTCCGCACCACCCTCTCAGTACCT  575 
 
Query  438   TCGAGGGTGGGCTCTGAGAGTGAGGATGAAGACCTCCTGAGCGAGCTGGAACTTGCAGAC  497 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 576   TCGAGGGTGGGCTCTGAGAGTGAGGATGAAGACCTCCTGAGCGAGCTGGAACTTGCAGAC  635 
 
Query  498   AGGGACGGGCAGCCGGGCTGCACGACAGCCACATGCCCCATTCAGGGAGCCCCAGACTCT  557 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 636   AGGGACGGGCAGCCGGGCTGCACGACAGCCACATGCCCCATTCAGGGAGCCCCAGACTCT  695 
 
Query  558   GGTAAATGCTCTGCTTCCTCCTGCCTGGATACTTCTAATGACTCTGACGACCTGGACGTG  617 
             |||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||| 
SNAPC4 696   GGTAAATGCTCTGCTTCCTCCTGCCTGGATACTTCTAATGACCCTGACGACCTGGACGTG  755 
 
Query  618   CTCAGAACCCGGCATGCCAGGCACACCCGGAAGCGGAGGCGGCTGGTGTGAGCAGCAGGA  677 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 756   CTCAGAACCCGGCATGCCAGGCACACCCGGAAGCGGAGGCGGCTGGTGTGAGCAGCAGGA  815 
 
Query  678   CAAGCACTTTCTCAGAAGCCCGTGGCCCTGCTGACGAGAGACAGCCCACCCCCAGCCTGC  737 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SNAPC4 816   CAAGCACTTTCTCAGAAGCCCGTGGCCCTGCTGACGAGAGACAGCCCACCCCCAGCCTGC  875 
 
 76 
 
Query  738   AAGAGAGGCAGCCAGAGGCCAGGTATCTGCTGGCCGCTGACCGACCAGGTCCGCATTGAA  797 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||| |||| 
SNAPC4 876   AAGAGAGGCAGCCAGAGGCCAGGTATCTGCTGGCCGCTGACCGACCAGGTCCGCAGTGAA  935 
 
Query  798   CAGAGGCGGGCCTGCCGACTGACTGTGTGGCATGGAGCATGGCTGTTCCCCAAGGTGCAC  857 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||| ||||| 
SNAPC4 936   CAGAGGCGGGCCTGCCGACTGACTGTGTGGCATGGAGCATGGCTGTTCCCCAAG-TGCAC  994 
 
Query  858   ACCTGAACACTTGGAGGAATAAAGTTCTTGTTTTTAATT  896 
             |||||||||||||||||||||||||||| |||||||||| 
SNAPC4 995   ACCTGAACACTTGGAGGAATAAAGTTCT-GTTTTTAATT  1032 
 
 
18. septin 3 [Homo sapiens] 
 
 Score =  547 bits (296),  Expect = 2e-152 
 Identities = 305/309 (98%), Gaps = 1/309 (0%) 
 Strand=Plus/Plus 
 
Query  1    CCCGTTTGCAGGGGCCGCTCGGCCCGGGGAAGCCCGCGCCCCGCTCAGCCTTGCAGCCCC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SEPT3 34   CCCGTTTGCAGGGGCCGCTCGGCCCGGGGAAGCCCGCGCCCCGCTCAGCCTTGCAGCCCC  93 
 
Query  61   GCGCCCGAAGCATCTCCCTGGAGGAACGGAGACAAAGGAGGATTCATGTCCAAAGGGCTC  120 
            ||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||| 
SEPT3 94   GCGCCCGGAGCATCTCCCTGGAGGAACGGAGACAAAGGAGGATTCATGTCCAAAGGGCTC  153 
 
Query  121  CCAGAGACCAGGACGGACGCAGCCATGTCAGAGCTGGTGCCTGAGCCCAGGCCTAAGCCA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SEPT3 154  CCAGAGACCAGGACGGACGCAGCCATGTCAGAGCTGGTGCCTGAGCCCAGGCCTAAGCCA  213 
 
Query  181  GCGGTGCCCATGAAGCCCATGAGCATCAACTCCAACCTGCTGGGCTACATCGGCATCGAC  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
SEPT3 214  GCGGTGCCCATGAAGCCCATGAGCATCAACTCCAACCTGCTGGGCTACATCGGCATCGAC  273 
 
Query  241  ACCATCATCGAGCAGATGCGCAAGAAGACCATGATTTACCGGTTTCGACTTCAACATCAT  300 
            ||||||||||||||||||||||||||||||||||   ||||||||||||||||||||||| 
SEPT3 274  ACCATCATCGAGCAGATGCGCAAGAAGACCATGAAG-ACCGGTTTCGACTTCAACATCAT  332 
 
Query  301  GGTCGTTGG  309 
            ||||||||| 
SEPT3 333  GGTCGTTGG  341 
 
19. Homo sapiens chromosome 6 clone RP11-20F2, complete sequence 
 
Score =  957 bits (518),  Expect = 0.0 
 Identities = 522/524 (99%), Gaps = 0/524 (0%) 
 Strand=Plus/Plus 
 
Query  36      AGCTCCTGACCTCAGGTGATCTGCCTGCCTTAGCCTCCCAAAGTGCTGGGACTACAGGCG  95 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130379  AGCTCCTGACCTCAGGTGATCTGCCTGCCTTAGCCTCCCAAAGTGCTGGGACTACAGGCG  130438 
 
Query  96      TGAGCCACCACGCCTGGCTGCTCCACCATCACTTTATCCTGCCTGTATTCCCCAGTTCTC  155 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130439  TGAGCCACCACGCCTGGCTGCTCCACCATCACTTTATCCTGCCTGTATTCCCCAGTTCTC  130498 
 
Query  156     CTCCACCAGTGTTTCCAGATCCAGAGCTGTTTAGACATAGGGTATTCAGAAAGTTGTGGT  215 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130499  CTCCACCAGTGTTTCCAGATCCAGAGCTGTTTAGACATAGGGTATTCAGAAAGTTGTGGT  130558 
 
Query  216     TTTGTTATTTTAAGATTTTAAAGTTCACTTCAATGTAAGGAAGTTAGTAAATGTCTGTGC  275 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130559  TTTGTTATTTTAAGATTTTAAAGTTCACTTCAATGTAAGGAAGTTAGTAAATGTCTGTGC  130618 
 
Query  276     TATGAGGAAAAGTTGATTCTGAATGGGTTGGTTTAACTCCTACAGTCTTAGATAAGAACT  335 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130619  TATGAGGAAAAGTTGATTCTGAATGGGTTGGTTTAACTCCTACAGTCTTAGATAAGAACT  130678 
 
Query  336     TGTTAATCGTATAAACATACTGTTTCAAAGAAAAAGCCAATTATAATTACTTTTATACAT  395 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130679  TGTTAATCGTATAAACATACTGTTTCAAAGAAAAAGCCAATTATAATTACTTTTATACAT  130738 
 
Query  396     ACATAAATCTATGAGTAAGATGAAGAAGTCAAATCAAAGGATTTTATTTCATTTCTGAGA  455 
 77 
 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130739  ACATAAATCTATGAGTAAGATGAAGAAGTCAAATCAAAGGATTTTATTTCATTTCTGAGA  130798 
 
Query  456     ATAATTTTGTATCTCACTTGCTGTTTCTCAATAATATTGTATAATTTTATTTCTGATTTT  515 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130799  ATAATTTTGTATCTCACTTGCTGTTTCTCAATAATATTGTATAATTTTATTTCTGATTTT  130858 
 
Query  516     TAAAAATAAGCAAACTGCCCTTGACCTCAAAAAAAAAAAAAAAA  559 
               ||||||||||||||||||||||||||||||| | |||||||||| 
Sbjct  130859  TAAAAATAAGCAAACTGCCCTTGACCTCAAAGAGAAAAAAAAAA  130902 
 
20. regulator of G-protein signaling 11 [Homo sapiens] 
 
 
 Score = 1376 bits (745),  Expect = 0.0 
 Identities = 745/745 (100%), Gaps = 0/745 (0%) 
 Strand=Plus/Plus 
 
Query  122   CTCATGACCAAGAGTGCAGATTTCCATAAGCGGGAGATCGAGTACTTCAGGAAAGCGCTG  181 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   666   CTCATGACCAAGAGTGCAGATTTCCATAAGCGGGAGATCGAGTACTTCAGGAAAGCGCTG  725 
 
Query  182   GGCAGGACCCGAGTGAAGTCCTCCGTCTGCCTTGAGGCGTACCTGAGTTTCTGCGGCCAG  241 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   726   GGCAGGACCCGAGTGAAGTCCTCCGTCTGCCTTGAGGCGTACCTGAGTTTCTGCGGCCAG  785 
 
Query  242   CGTGGACCCCACGATCCCCTCGTGTCGGGGTGCCTGCCCAGCAATCCCTGGATCTCAGAC  301 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   786   CGTGGACCCCACGATCCCCTCGTGTCGGGGTGCCTGCCCAGCAATCCCTGGATCTCAGAC  845 
 
Query  302   AATGACGCCTACTGGGTCATGAATGCCCCCACGGTGGCTGCCCCCACGAAGCTCCGTGTG  361 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   846   AATGACGCCTACTGGGTCATGAATGCCCCCACGGTGGCTGCCCCCACGAAGCTCCGTGTG  905 
 
Query  362   GAGAGATGGGGCTTCAGCTTCCGGGAGCTCCTGGAGGACCCCGTGGGGCGGGCCCACTTC  421 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   906   GAGAGATGGGGCTTCAGCTTCCGGGAGCTCCTGGAGGACCCCGTGGGGCGGGCCCACTTC  965 
 
Query  422   ATGGACTTTCTGGGAAAGGAGTTCAGTGGAGAAAACCTCAGCTTCTGGGAGGCATGTGAG  481 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   966   ATGGACTTTCTGGGAAAGGAGTTCAGTGGAGAAAACCTCAGCTTCTGGGAGGCATGTGAG  1025 
 
Query  482   GAGCTTCGATATGGAGCGCAGGCCCAGGTCCCCACCCTGGTGGATGCCGTGTACGAGCAG  541 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   1026  GAGCTTCGATATGGAGCGCAGGCCCAGGTCCCCACCCTGGTGGATGCCGTGTACGAGCAG  1085 
 
Query  542   TTCCTGGCCCCCGGAGCTGCCCACTGGGTCAACATCGACAGCCGGACCATGGAGCAGACC  601 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   1086  TTCCTGGCCCCCGGAGCTGCCCACTGGGTCAACATCGACAGCCGGACCATGGAGCAGACC  1145 
 
Query  602   CTGGAGGGGCTGCGCCAGCCCCACCGCTATGTCCTGGATGACGCCCAGCTGCACATATAC  661 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   1146  CTGGAGGGGCTGCGCCAGCCCCACCGCTATGTCCTGGATGACGCCCAGCTGCACATATAC  1205 
 
Query  662   ATGCTCATGAAGAAGGACTCCTACCCAAGGTTCCTGAAGTCTGACATGTACAAGGCCCTC  721 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   1206  ATGCTCATGAAGAAGGACTCCTACCCAAGGTTCCTGAAGTCTGACATGTACAAGGCCCTC  1265 
 
Query  722   CTGGCAGAGGCTGGGATCCCGCTGGAGATGAAGAGACGCGTGTTCCCGTTTACGTGGAGG  781 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   1266  CTGGCAGAGGCTGGGATCCCGCTGGAGATGAAGAGACGCGTGTTCCCGTTTACGTGGAGG  1325 
 
Query  782   CCACGGCACTCGAGCCCCAGCCCTGCACTCCTTCCCACCCCTGTGGAGCCCACAGCGGCT  841 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RGP   1326  CCACGGCACTCGAGCCCCAGCCCTGCACTCCTTCCCACCCCTGTGGAGCCCACAGCGGCT  1385 
 
Query  842   TGTGGCCCTGGGGGTGGAGATGGGG  866 
             ||||||||||||||||||||||||| 
RGP   1386  TGTGGCCCTGGGGGTGGAGATGGGG  1410 
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21. tubulin, beta 2A [Homo sapiens]  
  
 Score = 1417 bits (767),  Expect = 0.0 
 Identities = 776/780 (99%), Gaps = 2/780 (0%) 
 Strand=Plus/Plus 
 
Query  79   CCCGCCGGTCCACGCCGCGCACCGCTCCGAGGGCCAGCGCCACCCGCTCCGCAGCCGGCA  138 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  25   CCCGCCGGTCCACGCCGCGCACCGCTCCGAGGGCCAGCGCCACCCGCTCCGCAGCCGGCA  84 
 
Query  139  CCAAGCGCGAGATCGTGCACATCCAGGCGGGCCAGTGCGGCAACCAGATCGGCGCCAAGT  198 
            ||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  85   CCATGCGCGAGATCGTGCACATCCAGGCGGGCCAGTGCGGCAACCAGATCGGCGCCAAGT  144 
 
Query  199  TTTGGGAGGTCATCAGCGATGAGCATGGGATCGACCCCACAGGCAGTTACCATGGAGACA  258 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  145  TTTGGGAGGTCATCAGCGATGAGCATGGGATCGACCCCACAGGCAGTTACCATGGAGACA  204 
 
Query  259  GTGACTTGCAGCTGGAGAGAATCAACGTGTACTACAATGAGGCTGCTGGTAACAAATATG  318 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  205  GTGACTTGCAGCTGGAGAGAATCAACGTGTACTACAATGAGGCTGCTGGTAACAAATATG  264 
 
Query  319  TACCTCGGGCCATCCTGGTGGATCTGGAGCCTGGCACCATGGACTCTGTCAGGTCTGGAC  378 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  265  TACCTCGGGCCATCCTGGTGGATCTGGAGCCTGGCACCATGGACTCTGTCAGGTCTGGAC  324 
 
Query  379  CCTTCGGCCAGATCTTCAGACCAGACAACTTCGTGTTCGGCCAGAGTGGAGCCGGGAATA  438 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  325  CCTTCGGCCAGATCTTCAGACCAGACAACTTCGTGTTCGGCCAGAGTGGAGCCGGGAATA  384 
 
Query  439  ACTGGGCCAAGGGCCACTACACAGAGGGAGCCGAGCTGGTCGACTCGGTCCTGGATGTGG  498 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  385  ACTGGGCCAAGGGCCACTACACAGAGGGAGCCGAGCTGGTCGACTCGGTCCTGGATGTGG  444 
 
Query  499  TGAGGAAGGAGTCAGAGAGCTGTGACTGTCTCCAGGGCTTCCAGCTGACCCACTCTCTGG  558 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  445  TGAGGAAGGAGTCAGAGAGCTGTGACTGTCTCCAGGGCTTCCAGCTGACCCACTCTCTGG  504 
 
Query  559  GGGGCGGCACGGGGTCCGGGATGGGCACCCTGCTCATCAGCAAGATCCGGGAAGAGTACC  618 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  505  GGGGCGGCACGGGGTCCGGGATGGGCACCCTGCTCATCAGCAAGATCCGGGAAGAGTACC  564 
 
Query  619  CAGACCGCATCATGAACACCTTCAGCGTCATGCCCTCACCCAAGGTGTCAGACACGGTGG  678 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  565  CAGACCGCATCATGAACACCTTCAGCGTCATGCCCTCACCCAAGGTGTCAGACACGGTGG  624 
 
Query  679  TGGAGCCCTACAACGCCACCCTCTCGGTCCACCAGCTGGTGGAAAACACAGATGAAACCT  738 
            ||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||| 
BTub  625  TGGAGCCCTACAACGCCACCCTCTCTGTCCACCAGCTGGTGGAAAACACAGATGAAACCT  684 
 
Query  739  ACTCCATTGATAACGAGGCCCTGTATGACATCTGCTTCCGCACCCTGAAGCTGACCACCC  798 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
BTub  685  ACTCCATTGATAACGAGGCCCTGTATGACATCTGCTTCCGCACCCTGAAGCTGACCACCC  744 
 
Query  799  CCCACCTACGGGGACCTCAACCACCTGGTGTCGGC-ACCATGAGCGGGGTCACCACCTGC  857 
            || |||||||||||||||||||||||||||||||| |||||||||||||||||||||||| 
BTub  745  CC-ACCTACGGGGACCTCAACCACCTGGTGTCGGCCACCATGAGCGGGGTCACCACCTGC  803 
 
 
22. rho-related BTB domain containing 3 
 
 
 Score = 1219 bits (660),  Expect = 0.0 
 Identities = 671/676 (99%), Gaps = 2/676 (0%) 
 Strand=Plus/Minus 
 
Query  37        GCAGAGGTAGCTTTGTCTTCCTCCTCTTTGTGTCTTCAATTCCAAATGCAATGATTGGCA  96 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP           GCAGAGGTAGCTTTGTCTTCCTCCTCTTTGTGTCTTCAATTCCAAATGCAATGATTGGCA  
43671340 
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Query  97        CAAGTTGATTCTCGGTAATAATCTGTTGAAGTGATCCAGGCTGAACTGAAGGCTGGCAGT  156 
                 || | ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43671339  CATGCTGATTCTCGGTAATAATCTGTTGAAGTGATCCAGGCTGAACTGAAGGCTGGCAGT  
43671280 
 
Query  157       GTGTATTCGTGGTTTTCTAAGGTGGTGGAAGTAGAGAGCCCTGGCCACTCACGGCCCTAT  216 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43671279  GTGTATTCGTGGTTTTCTAAGGTGGTGGAAGTAGAGAGCCCTGGCCACTCACGGCCCTAT  
43671220 
 
Query  217       CCAGCGCTGCCTTTGTGTGGTGCAGCAGTAGCTAGAGAGCCTAGCAAGCTTTTCCTAGAG  276 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43671219  CCAGCGCTGCCTTTGTGTGGTGCAGCAGTAGCTAGAGAGCCTAGCAAGCTTTTCCTAGAG  
43671160 
 
Query  277       AGTTAATTCAGTTCGGTGAGTTCAGTGAGCAGTTTGGGCTGAGAGAGCCCTCAAAATTCA  336 
                 ||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||| 
RhoGTP 43671159  AGTTAATTCAGTTCGGTGAGTTCAGTGAGCAGTATGGGCTGAGAGAGCCCTCAAAATTCA  
43671100 
 
Query  337       ACGTAGCACTGGCTCTCCCAGCAGCAGGCATTGTTCAGGTGAGACAGAATGGTTGCCTGA  396 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43671099  ACGTAGCACTGGCTCTCCCAGCAGCAGGCATTGTTCAGGTGAGACAGAATGGTTGCCTGA  
43671040 
 
Query  397       GGAAGTAGTGTGCTGGGGAGACTGCAGGGATTAAGGTCATCCTCTTCCAGATTTTCATTA  456 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43671039  GGAAGTAGTGTGCTGGGGAGACTGCAGGGATTAAGGTCATCCTCTTCCAGATTTTCATTA  
43670980 
 
Query  457       AGTCTGAAATGCTCTCCTTGGCTCCACAAGAGATCCTCTTGCTATTCCTACTGTGGTGTA  516 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43670979  AGTCTGAAATGCTCTCCTTGGCTCCACAAGAGATCCTCTTGCTATTCCTACTGTGGTGTA  
43670920 
 
Query  517       CGGACAGCTTATGGTTTACTTCTTACAGTTTCCTGTTTCAGATAAGGGGAAGCATGGCCA  576 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43670919  CGGACAGCTTATGGTTTACTTCTTACAGTTTCCTGTTTCAGATAAGGGGAAGCATGGCCA  
43670860 
 
Query  577       AGATGGTTCTGTGAGTCAGGCCCAGAAGGGTAATGGGGTTGTTTTCTTGGGAGGCACATG  636 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
RhoGTP 43670859  AGATGGTTCTGTGAGTCAGGCCCAGAAGGGTAATGGGGTTGTTTTCTTGGGAGGCACATG  
43670800 
 
Query  637       GGCACGGGTAGTATTATTAA-ATTTCAAGCCAATTGGAAAAGGATTGATGTTTCATTATA  695 
                 |||||||||||||||||||| ||||||||||||||||||| ||||||||||||||||||| 
RhoGTP 43670799  GGCACGGGTAGTATTATTAATATTTCAAGCCAATTGGAAA-GGATTGATGTTTCATTATA  
43670741 
 
Query  696       AAAATATGAAGCAAAA  711 
                 |||||||||||||||| 
RhoGTP 43670740  AAAATATGAAGCAAAA  43670725 
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APPENDIX B: CLONTECH TECHNICAL SUPPORT  
  
From: Duygu Esen [mailto:duygu.esen@yahoo.com] 
Sent: jeudi 24 avril 2008 13:07 
To: CLONTECH TECH SUPPORT 
Subject: Re: non-coding sequences after screening of pretransformed human fetal 
MM library 
 
 Dear Klaus, 
 
My bait is a microtubule severing protein, katanin. it is a cytosolic protein so i can't 
understand why it could interact with non-coding sequences. 
I blasted my results first to human genome, where they are not matching any coding 
sequence of a gene, then i investigated for their ORF. but nothing present as i 
mentioned. 
 
The other results (the coding ones) seem to be relevant by the way... 
Regards 
 
Duygu 
 
 
From: CLONTECH TECH SUPPORT <tech@clontech-europe.com> 
To: Duygu Esen <duygu.esen@yahoo.com> 
Cc: "tez@tez.com.tr" <tez@tez.com.tr> 
Sent: Monday, April 28, 2008 5:11:30 PM 
Subject: RE: non-coding sequences after screening of pretransformed human fetal 
MM library 
 
Dear Duygu 
 
So, I´m wondering where do these clones map to human genomic DNA. Are these 
intronic sequences? I suspect they might stem from incompletely spliced mRNAs. 
 
Unfortunately it is not always predictable which clones a yeast two-hybrid screen 
will pull out. 60 clones is a perfectly reasonable number of hits though. If you found 
several interaction partners that activate all reporters, that are not self-activating and 
“make sense” after analyzing the protein sequences, then I would say that this was a 
successful screen! 
 
 You are certainly aware that candidate interactions from a yeast two-hybrid screen 
need to be confirmed with other methods. At this point I would move on to an IP 
assay as soon as possible, e.g. with the Matchmaker Chemiluminescent Co-IP 
System or pCMV-Myc & pCMV-HA Vector Set. 
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 Hope this helps 
Best regards 
Klaus 
 
From: Duygu Esen [mailto:duygu.esen@yahoo.com] 
Sent: mercredi 18 juin 2008 14:37 
To: CLONTECH TECH SUPPORT 
Subject: construction of pACT2 library 
 
In our lab, pretransformed cDNA library is being used. Now we are in the step of 
interchanging vector from yeast expression (pACT2) to mammalian expression (c-
myc). While trying to insert the cDNA fragments in frame with c-myc epitope, one 
question came to my mind. 
 
mRNA pool is primed with oligo dt-XhoI and after cDNA amplified EcoRI adaptor 
sequence is ligated (Cat no 638831, certificate of analysis). Adapter sequence is in 
frame with pACT2, after adaptor sequence cDNA should start either with ATG or a 
sequence which is in frame with ATG. How can you achieve to obtain cDNA to be in 
frame with pACT2. 
 
Regards, 
 
Duygu Esen 
 
Research Assistant 
Molecular Biology Genetics and 
Biotechnology Research Center 
Istanbul Technical University 
 
 
 
From: CLONTECH TECH SUPPORT <tech@clontech-europe.com> 
To: Duygu Esen <duygu.esen@yahoo.com> 
Sent: Wednesday, June 18, 2008 4:00:25 PM 
Subject: RE: construction of pACT2 library 
 
Dear Duygu 
 
Thank you very much for contacting Clontech. 
 
The Matchmaker libraries are cloned directionally but randomly in all 3 reading 
frames, so that 1/3 of all clones will be in-frame with the Gal4 AD. 
 
 Hope this answers your question. 
 
Best regards 
 
Klaus 
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RESUME: 
 
Duygu Esen was born on September 11 1983, in Adana. She went Elementary School in 
Seyhan, Adana. She graduated from ATO Anatolian High School in Adana. She attended to 
Middle East Technical University, Molecular Biology and Genetics Department at 2001 and 
earned her Bachelor of Science degree from the department at 2005. She pursued her 
academic studies in Istanbul Technical University, Molecular Biology-Genetics and 
Biotechnology master program at 2005.  She is still carrying her studies in this department. 
